· web viewvaporciyan, a.a., walsh, g.l., sinner, m., and roth, j.a. the university of texas m. d....

CURRICULUM VITAE

NAME: Joe B. Putnam, Jr., M.D.

OFFICE ADDRESS: Department of Thoracic SurgeryVanderbilt University Medical Center609 Oxford House1313 21st Avenue SouthNashville, TN 37232–4682 Phone: (615) 343-9202Fax: (615) 322-3079E - mail: [email protected]

Thoracic Surgeryc/o Surgical ServicesNashville VA Medical CenterVA Tennessee Valley Health Care System (TVHS)1310 24th Avenue SouthNashville, Tennessee 37212 - 2637Phone: (615) 327 - 5356 x 5615Hospital: (615) 327 - 4751Fax: (615) 321 - 6342

Date/Place of Birth: September 26, 1953 / Franklin, NC

HOME ADDRESS: 515 Westview AvenueNashville, TN 37205-3283 (615) 298 - 4272Spouse: Jacqueline

CITIZENSHIP: USA

Military or Other Governmental Service

Director of Surgical Services, Naval Reserve Combat Zone Fleet Hospital 21, Dallas, TX 1997 - 1998

Head, Division of Cardiothoracic Surgery, Naval Hospital - San Diego, CAOPERATION DESERT STORM 1990 - 1991

Navy Commendation Medal 1991Captain (O-6, retired) , Medical Corps, United States Naval Reserve 1985 - 2011

PRESENT TITLE AND AFFILIATION:

Primary Appointment Professor of Surgery and ChairmanIngram Professor of Cancer ResearchDepartment of Thoracic SurgeryVanderbilt University Medical CenterNashville, TN

Secondary Appointment Professor of Biomedical InformaticsDepartment of Biomedical InformaticsVanderbilt University Medical CenterNashville, TN

mailto:[email protected]

Joe B. Putnam, Jr., M.D. Rev. December 2012

EDUCATION:

Postgraduate Education and Training

Resident in Thoracic Surgery, University of Michigan, Ann Arbor, MI 1986 - 1988Chief Resident in Surgery, University of Rochester School of Medicine

and Dentistry, Rochester, NY 1985 - 1986Senior Assistant Resident in Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY 1984 - 1985Medical Staff Fellow, Surgery Branch, National Cancer Institute, National Institutes of Health,

Bethesda, MD 1981 - 1984Junior Assistant Resident in Surgery, Johns Hopkins Hospital, Baltimore, MD 1980 - 1981Surgical Internship, Johns Hopkins Hospital, Baltimore, MD 1979 - 1980

Degree-Granting Education

The University of North Carolina at Chapel Hill, Doctor of Medicine, 1975 - 1979The University of North Carolina at Chapel Hill, A.B. with Honors in Chemistry 1971 - 1975

Additional Education

“Understanding the New World of Health Care”. John F. Kennedy School of Government, Harvard University, November 15 - 23, 1997.

Rice Program for Managers, Rice University, School of Business, Houston, TX, January 16, 1999 - March 27, 1999.

National Comprehensive Cancer Network, NCCN Practice Guidelines for Esophageal Cancer, 2000

Finance and Budgeting for Non - Financial Healthcare Professionals, University of Texas MD Anderson Cancer Center, Houston, TX - - October 24, 2002.

American College Surgeons, Clinical Trials Methods Course – December, 2002.

IRB Human Subjects Protections Training Program, Vanderbilt University Institutional Review Board, March, 2004.

Clinical Trials Program, American College of Surgeons, Chicago, IL - - June 16 - 19, 2004.

Clinical Trials Research Methods, The Society of Thoracic Surgeons and the University of Colorado; Denver CO - - August, 2004

Keck School of Public Health, Center for Continuing Professional Education, Program for Chiefs of Clinical Services, Harvard University, Boston, MA - - January 16 - 28, 2005.

Vanderbilt University Medical Center, Academic Leadership Program, Nashville, TN - - March – December, 2005

CREDENTIALS:

Board Certification

American Board of Surgery 23087 1987American Board of Thoracic Surgery 4870 1989 - 1999,

Recertified 1998 - 2009Recertified 2008 - 2019

2


Licensures Expiration Dates

North Carolina Medical Board 24983 9/26/13DEA Registration BP8620571 3/31/13Tennessee Board of Medical Examiners 38176 9/30/13

EXPERIENCE/SERVICE:

Academic Appointments

Assistant Professor, Division of Thoracic and Cardiovascular Surgery, University of Texas School of Medicine, Houston, TX 1988 - 1994Assistant Surgeon, Assistant Professor of Surgery, Department of Thoracic Surgery, University of Texas M. D. Anderson Cancer Center, Houston, TX 1988 - 1994Associate Surgeon, Associate Professor of Thoracic & Cardiovascular Surgery,

Department of Thoracic & Cardiovascular Surgery,University of Texas M. D. Anderson Cancer Center, Houston, TX 1994 - 2000

Deputy Chairman, Department of Thoracic and Cardiovascular Surgery,University of Texas M. D. Anderson Cancer Center, Houston, TX 1995 - 2004

Professor of Surgery, Department of Thoracic and Cardiovascular Surgery,University of Texas M. D. Anderson Cancer Center, Houston, TX 2000 - 2004

Chief, Section of Cardiothoracic Surgery, Nashville VA Medical Center,VA Tennessee Valley Health Care System (TVHS), Nashville, TN 2004 - 2005

Professor of Surgery and Chairman, Department of Thoracic Surgery,Vanderbilt University Medical Center, Nashville, TN 2004 - present

Academic Administrative Appointments/Responsibilities

University of Texas M. D. Anderson Cancer CenterDeputy Director, Surgical Intensive Care Unit 1991 - 1992Search Committee for Chairman of the Dept. of Anesthesiology 1992 - 1992Member - Division of Surgery and Anesthesiology Promotions Committee 1995 - 1997Deputy Chair, Department of Thoracic and Cardiovascular Surgery 1995 - 2004Director, Surgical Education and Training, Department of

Thoracic and Cardiovascular Surgery 1992 - 2004Member, Division of Surgery Promotions Committee 1996 - 1998Member, Operating Room Committee 1997 - 2004Program Director, Clinical and Resident Education,

Department of Thoracic and Cardiovascular Surgery 1997 - 2004Chairman, Division of Surgery Faculty Promotions Committee 1998 - 2004Chairman, Operating Room Subcommittee on “Correct Site/Side” Surgery 2002 - 2004Chairman, Revenue Cycle Advisory Committee 2002 - 2004Chairman, ad hoc Clinical Faculty Recognition Committee 2002 - 2003

Vanderbilt University Medical Center

Program Director, Residency Program in Thoracic and Cardiac Surgery 2004 - presentMember, Section of Surgical Sciences Promotion Committee 2005 - presentMember, Section of Surgical Sciences Quality Control Committee 2006 - present

Institutional Committee Activities

University of Texas M. D. Anderson Cancer CenterAlternate, Research Committee 1989 - 1994Member, Conduct of Care Subcommittee 1989 - 1994

3


Institutional Committee Activities (cont.)

Thoracotomy Videotape Task Force 1991 - 1992Member, Institutional Clinical Research Committee 1991 - 1992Member, Faculty Senate By - Laws Committee 1992 - 1994Member, Graduate Medical Education Committee 1992 - 1995Member, Medical Practice Subcommittee of the Medical Staff 1992 - 1995Member, GI Tumor Group 1993 - 1993Chairman, Faculty Senate Finance Committee 1993 - 1995Member, Task Force on Incentive - based Compensation for Faculty 1994 - 1995Member, Disaster Subcommittee of the Medical Staff 1995 - 1995Member, Credentials Committee of the Medical Staff (CCMS) 1995 - 1996Member, Executive Committee of the Faculty Senate 1995 - 1997Member, Executive Committee of the Medical Staff, (ECMS) 1995 - 1997Member, Conflict of Interest Committee 1995 - 1998Participant, Telemedicine Conferences, M. D. Anderson Cancer Center Orlando 1995 - 2000Member, Clinical/Technical Team - Second Opinion at a Distance/Telemedicine 1997 - 1998Member, Roster of Services Committee 1997 - 1997Network Development/Contracting Team 1997 - 1999Managed Care Operations Committee 1997 - 1999Member, Guidelines & Pathways Committee 1997 - 1998Member, Cancer Manager Project Leaders 1997 - 1999Member, Audit Committee 1997 - 2001Member, 1997 Faculty Achievement Award Parent Committee 1997 - 2001Member, PET Program Steering Committee 1998 - 2000Member, Cancer Consultant Operations Committee 1998 - 1999Co - Chairman, Committee on Faculty Peer and Grievance Review 1998 - 2000Member, Graduate Medical Education Committee 1999 - 2004Co - Chairman, Diagnostic Imaging Users Group Committee 1999 - 2000Member, Physicians Referral Service Executive Committee

Elected Representative – Division of Surgery 1999 - 2004Member, Diagnostic Imaging Search Committee 2000 - 2001Conflict Management Advisory Committee 2000 - 2003Chairman, Conflict Management Advisory Committee 2001 - 2002Ombudsman Selection Committee 2000 - 2001Member, Charles LeMaistre Outstanding Achievement Award Committee 2000 - 2000Member, Promotion and Tenure Committee 2000 - 2004 Chairman, GME Internal Review Sub - Committee for Pathology 2002 - 2002Member, Credentials Committee of the Medical Staff 2002 - 2004Member, Conflict of Interest Committee 2002 - 2004Member, ad hoc Committee for Review of Non - Tenured Clinical Faculty 2003 - 2004

Vanderbilt University Medical Center

Member, Vanderbilt Ingram Cancer Center 2004 - PresentMember, Medical Center Medical Board 2004 - Present

PROFESSIONAL MEMBERSHIPS/ACTIVITIES

Professional Society Activities, with Offices Held

American Association for Thoracic Surgery:Member, Scientific Advisory and Government Relations Committee 2004 – 2012Member, Council on Cardiothoracic Surgery 2009 - 2012Member, Thoracic Surgery Joint WorkforceMember, Tech - Con Workforce 2007 – 2008

4

Joe B. Putnam, Jr., M.D. Rev. December 2012Co - Chair, Tech - Con Workforce 2007 – 2008AHRQ/CMS Subcommittee 2004 – 2007Member, Ad Hoc Program Review Committee 2009 – 2010

Professional Society Activities, with Offices Held (cont.)

American Board of Thoracic Surgery, Director 2013 – 2018American Board of Thoracic Surgery, guest examiner 2004 - presentAmerican College of Chest Physicians American College of Surgeons:

Web Portal Committee 2004 - presentBoard of Governors (representing Southern Thoracic Surgical Association) 2007 – presentAdvisory Council for Cardiothoracic Surgery 2011 – present

American College of Surgeons Oncology GroupChair, Thoracic Organ Site Committee, 2002 - 2010Member, Executive Committee 2002 - 2010

American Society for Clinical OncologyMember, Scientific Program Committee 2008 – 2011Member, Cancer Communications Committee 2012 – 2013

American Surgical Association, Fellow 2011 - 2012Bayer Fellowships in Blood Conservation Selection Committee 2005 - 2008European Association for Cardiothoracic SurgeryGeneral Thoracic Surgical ClubHouston Surgical Society 1996 - 2004International Association for the Study of Lung Cancer

Chair, Consensus Conference Committee on Adjuvant Therapy 1993Member, Education Committee 2003Chair, Bylaws Committee 2006 - 2007Member, Bylaws Committee 2005 – 2009

Joint Council on Thoracic Surgery Education, Assessment Committee 2012Nashville Surgical Society 2005 - presentSigma Xi (Life Member) 1977 - presentSociety of Thoracic Surgeons:

Member, National Database Task Force 2002 - 2003Chair, Workforce on Research and Clinical Trials 2003 - 2016Member, Workforce on Annual Meeting 2007 - 2008Co-Chair, Tech-Con Workforce 2007 - 2008Member, Workforce on Media Relations and Communications 2007 - 2013Member, Workforce on Access and Publications 2008 - 2011

Society of Surgical OncologySouthern Surgical AssociationSouthern Thoracic Surgical AssociationTexas Surgical Association The John Alexander SocietyUT MD Anderson AssociatesAmerican Radium Society 1995 - 2005National Quality Forum Perioperative Steering Committee 2008 - 2010

Technical Advisory Panel 2010 - 2012Thoracic Surgery Directors Association 2004 - 2010

Nominating Committee

Local/State

Planning Committee, Thoracic Surgery Lecture Series, Baylor College of Medicine, Department of Cardiovascular and Thoracic Surgery, Houston, TX 1996 - 2004.

Member, Advisory/Operations Committee for the Center of Excellence in Minimally Invasive Surgery at Hermann Hospital, University of Texas Health Science Center at Houston 1993 - 1994Co - Chair, Esophageal Cancer Session. Multidisciplinary G.I. Cancer Retreat, University of Texas M. D.

5

Joe B. Putnam, Jr., M.D. Rev. December 2012 Anderson Cancer Center, Houston, TX 1992Coordinating Committee Interdisciplinary Oncology Conference, University of Texas Medical School, Houston, TX 1990 - 1991Tennessee Chapter, American College of Surgeons 2009-Present

Professional Society Activities, with Offices Held (cont.)

Charter Member, Institute for Responsible Dispute Resolution, Houston, TX 2001

National and International:

International Association for the Study of Lung CancerChair, Surgery Committee, 11th World Conference on Lung Cancer, Barcelona, Spain July 2005Chair, Bylaws Committee 2005 - present

NCI Thoracic / Lung Intergroup 2003 - 2010NCI GI Intergroup Esophagogastric Disease Site Working Group 2004 - presentProgram Committee, American Association of Thoracic Surgery 2004 - 2006American College of Surgeons Oncology Group (ACOSOG) 2002 - presentCommittee Member, American College of Surgeons, Commission on Cancer Disease Site Team 2002 - presentCommittee Member, Society of Thoracic Surgeons, National Databases Resource Group, 2002 - presentMember, Society of Thoracic Surgeons, Nomenclature and Coding 2001 - 2005Member, Intergroup Lung Cancer Working Council, Randomized Trial Neoadjuvant Chemotherapy and Surgery versus Surgery Alone for Early Stage Lung Cancer “S9900” 1998Member, Radiation Therapy Oncology Group Thoracic Surgery Subcommittee 1989 - 2001Member, National Database Committee, National Thoracic Surgery Database,

Society of Thoracic Surgeons, Chicago, IL 1995 - 1997Chairman, Video Thoracoscopic Surgery Session, 4th European Congress of Video Surgery,

Istanbul, Turkey 1994Member, Original Investigators Committee, 58th Annual Scientific Assembly,

American College of Chest Physicians 1991National Cancer Institute, Thoracic Malignancies Steering Committee 2008 - 2010

TEACHING

Courses Taught

Instructor Advanced Cardiac Life Support Provider Course, The University of Texas M. D. Anderson Cancer Center, 1994 - 1998.

Training Programs

Video - Assisted Thoracoscopy Training Course, Department of Thoracic Surgery, 1992Coordinator, Third Year Students (Two week rotation) in Thoracic Surgery, 1988 - 2000

Other Educational Programs

Teaching Assistant - General Chemistry, Department of Chemistry, University of North Carolina at Chapel Hill 1974 - 1975.

Student Project Director, Student Originated Studies, National Science Foundation, Department of Zoology, University of North Carolina at Chapel Hill 1988 - 1994Surgical Lecture Series, Department of Surgery, University of Rochester Strong Memorial Hospital, Rochester,

New York 1985 - 1986Thoracic Surgery Lecture Series, Department of Thoracic Surgery, University of Texas M. D. Anderson Cancer

Center 1988 - 1994Instructor, Advanced Trauma Life Support Provider Courses, Southeast Trauma Educ Foundation 1994 - 1998Director, Clinical Education and Training, Department of Thoracic and Cardiovascular Surgery, University of

Texas M. D. Anderson Cancer Center 1996 - 2004Moderator, Institutional Grand Rounds Pearls - The Art and Science of Medicine, University of Texas M. D.

Anderson Cancer Center, Sep, 1999

6

Joe B. Putnam, Jr., M.D. Rev. December 2012Moderator, Institutional Grand Rounds Pearls - The Art and Science of Medicine, University of Texas M. D.

Anderson Cancer Center Jun, 2001Moderator, Institutional Grand Rounds Pearls - The Art and Science of Medicine, University of Texas M. D.

Anderson Cancer Center Sep, 2002

Other Educational Programs (cont.)

Program Director, Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN 2004 - presentContributor, 2010 NSCLC education.org on-demand webinar, “The New (2010) AJCC Oct, 2010

Lung Cancer Staging System”

Supervisory Teaching

Direct SupervisionUndergraduate, Medical, and Allied Health Students

Graduate and Postgraduate Students Suk - Joo Rha, M.D., Postdoctoral Fellow 1/98 - 12/99Imran Mohiuddin, M.D., Researcher 1/99 - 12/01Freddy Angulo, M.D., Observer 2/99 - 9/00Jin - Sun Kim, M.D., Postdoctoral Fellow 7/05 - 3/08Lori Ferranti, PhD Candidate 2006 – 2009

Mentoring: Faculty: Eric S. Lambright, M.D. 2004 - present Eric L. Grogan, M.D. 2008 - present Residents: Gary Hochheiser, M.D. 2004

Tarek Absi, M.D. 2004 - 2005Robert DuBose, M.D. 2005 - 2007

Tammy Baxter, M.D. 2006 - 2008 Jared Antevil, M.D. 2007 - 2009 Alex Karavas, M.D. 2008 - 2010 Daniel Cuadrado, M.D. 2008 - 2012 James Mykytenko, M.D. 2009 - 2011

Nikhil Jaik, MB.,B.S. 2010 - 2012Aaron Hoffman, M.D. 2011 - 2014Aundrea Oliver, M.D. 2011 – 2014Elena Ziarnik, M.D. 2012 - 2015

Pre-Doctoral Trainee: Lori Ferranti 2005 - 2009Stephen Deppen . 2008 - present

Outside of Current Institution:

Organization of National or International Conferences/Symposia

The Society of Surgical Oncology’s 49th Cancer, Thoracic Oncology Session; Symposium, Atlanta, GA, Moderator, 1997

American Radium Society 80th Annual Meeting, Lung Cancer, Monte Carlo, Monaco, Discussion Panel 1998

American Radium Society 80th Annual Meeting, Esophageal CancerMonte Carlo, Monaco, Moderator 1998

American Radium Society Program Committee, 2003American Association for Thoracic Surgery, Program Review Committee 2003 - presentChair, Surgery Abstract Committee, International Association for the Study of Lung

Cancer; World Congress, Barcelona, Spain 2005

7


RESEARCH

Grants and Contracts

Principal Investigator, A Prospective Randomized Study of Pleural Drainage vs. Tube Thoracostomy and Pleurodesis for Treatment of Pleural Effusions, Denver Biomaterials, Inc., Golden CO, 4/4/94 - 4/4/96, $33,750 ($16,875/year)

Principal Investigator, Ethicon Endosurgery, Residents and Fellows Training and Development, Cincinnati, OH, 5/1/94 - 4/30/96, $12,811 ($6,400/year)

Institutional Principal Investigator, Co - Investigator for National Study, A Multicenter Phase III Trial to Evaluate the Efficacy of Recombinant Human GM - CSF (rhu GM - CSF) for Prophylaxis of Postoperative Infection, Immunex Corporation, Seattle, WA, 4/95 - 4/96, $250,000 ($250,000/year)

Principal Investigator, In Vitro and in Vivo Studies to Enhance Isolated Single Lung Perfusion For the Treatment of Sarcomatous Pulmonary Metastases In a Rodent Model, University of Texas M. D. Anderson Cancer Center, Houston, TX, Physician Referral Service Research2/1/98 - 1/31/99, Award $22,178 ($22,178/year)

Co - Investigator, University of Texas SPORE in Lung Cancer, NCI 9/1/98 - 8/31/99, $3,828,945 ($3,828,945/year)

Co - Investigator, University of Texas SPORE in Lung Cancer, NIH 9/01/99 - 8/31/01, $24,960 ($12,480/year)

Co - Investigator, Restoration of Apoptosis in Cancer, NIH/NCI 5/01/00 - 4/30/01, $690,030 ($690,030/year)

Principal Investigator, Evaluation of Radiofrequency Ablation (RFA) for Malignant Lung Tumors, Rita Medical Services, Mountain View, CA8/10/00 - 8/31/01, $17,090 ($17,090/year)

Co-Investigator, Using a novel system to assess and manage post - operative pain and other symptoms in patients with lung cancer, University of Texas M. D. Anderson Cancer Center, Houston, TX12/01/01 - 11/30/03, $299,884 ($149,942/year)

Institutional Principal-Investigator, A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2NO), II (T2 - 2N1, T3NO) and Selected IIIA (T3N1) Non - Small Cell Lung Cancer (NSCLC), Southwest Oncology Group (SWOG), San Antonio, TX1/10/01 - 12/31/04, $256,950 ($85,650/year)

Co - Investigator, 5 U10 CA076001 05, American College of Surgeons Oncology Group, Duke University, Durham, NC 5/01/02 - 4/30/10, ($128,000).

Database Administrator, University of Texas SPORE in Lung Cancer, NIH9/01/02 - 4/30/03, ($100,000) Principal Investigator

Principal Investigator, “A Multi - Center, Randomized, Double - Blind, Placebo - Controlled, Parallel Design, 2 - Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung Cancer or Esophageal Cancer” Bayer – BAY Number BAY a 0128; Study Number 11800 January 1, 2006 – December 31, 2008

Patents

#6,699,231 March 2, 2004; Sterman WD, Stevens JH, Gifford III HS, Siegel LC, Putnam, JB Jr.. Assignee: Heartport, Inc. (Redwood City, CA (appl. No, 223229; Filed December 30, 1998). “Methods and apparatus for perfusion of isolated tissue structure”.

Protocols

Collaborator, A Prospective Randomized Three - Arm Phase III Trial Comparing Trimodality Therapy Cisplatin, 5 - FU, Radiotherapy and Surgery, Adjuvant Chemotherapy (Cisplatin and 5 - FU) and Surgery Alone For Esophageal Cancer, CALGB 9X9L, University of Maryland School of Medicine, Baltimore, MD, 1995

Co - Investigator, A Phase I Study of E1A Gene Therapy for Patients with Metastatic Breast or Epithelial Ovarian Cancer that Overexpress HER - 2/neu, DM 94 - 129, University of Texas M.D. Anderson Cancer Center, 1996 - 1998 (Closed 4/13/98)

8


Protocols (cont.)

Collaborator, A Phase II Study of - Difluoromethyl ornithine (DFMO) in Patients with Barrett’s Esophagus with Dysplasia, DM 98 - 204, University of Texas M.D. Anderson Cancer Center, Division of Medicine, 1999 - 5/02

Collaborator, Phase II Study of Preoperative CPT - 11/Cisplatin followed by Concurrent 5 - FU/Taxol and Radiotherapy in Patients with Potentially Resectable Carcinoma of the Esophagus or GE Junction DM98 - 349, University of Texas M.D. Anderson Cancer Center, 1999 - 11/00

Collaborator, An Efficacy Study of Adenoviral Vector Expressing Wild type p53 (AD - p53) Administered Intralesionally as an Adjunct to Radiation Therapy in Patients with Non - Small Cell Cancer, GS 97 - 183, University of Texas M.D. Anderson Cancer Center, 1998 - 6/00

Principal Investigator, Lung Transplantation for End Stage Pulmonary Diseases, HSC - MD - 90 - 061, University of Texas Health Science Center at Houston, 1990 - 1993 (Closed)

Principal Investigator, Acute and Chronic Studies on Radioablation of Porcine Lung Parenchyma, IACUC 02 - 99 - 0112, University of Texas M. D. Anderson Cancer Center, 1999 - 2002

Study Co - Chairman, Measurement and Prediction of Postoperative Pain and Analgesic Requirement, ID00 - 370, University of Texas M. D. Anderson Cancer Center, 2001

Collaborator, Preoperative Cardiopulmonary Limit Reached (Closed) Function Testing to Predict Postoperative Morbidity and Mortality in the High Risk Patient with Resectable Lung Cancer, ID 89 - 009, University of Texas M.D. Anderson Cancer Center, 1989 - 1993

Principal Investigator, A Study of Lung Transplantation for the Cancer Patients: Treatment of Patients with Pulmonary Metastases from Osteogenic and Soft Tissue Sarcomas, ID89 - 030, University of Texas M.D. Anderson Cancer Center, 1987 - 1988(Closed)

Collaborator, Phase III Double - Blind Randomized Trial of 13 - cis Retinoic Acid (13 - cRA) to Prevent Second Primary Tumors (SPTs) in Stage I Non - small Cell Lung Cancer, ID 91 - 025, University of Texas M.D. Anderson Cancer Center, 1992 - 9/98

Collaborator, Early Detection of Second Primary Lung Cancers By Sputum Cytology Immunostaining, ID 91 - 029, University of Texas M.D. Anderson Cancer Center, 1992 - 6/00

Co - Chairman, Phase II study of combined modality treatment for resectable non - small cell superior sulcus tumor (SST), ID 92 - 038, University of Texas M.D. Anderson Cancer Center, 1993 – 2004

Co - Investigator, An open study to assess concentration of CP - 99219 in whole lung tissue and serum after administration of multiple doses to patients undergoing thoracotomy, ID 94 - 046, University of Texas M.D. Anderson Cancer Center, 1994 - 1997

Collaborator, A phase I study of continuous infusion low dose paclitaxel and concurrent radiotherapy for unresectable esophageal cancer,. ID 95 - 071, University of Texas M.D. Anderson Cancer Center, 1995 - 8/01

Principal Investigator, Phase I evaluation of single pass pulmonary perfusion with Adriamycin for sarcomatous (pulmonary) metastases, ID 95 - 219, University of Texas M.D. Anderson Cancer Center 1995 - 2004

Collaborator, A multi - center study of the correlation between the findings of atypical/malignant cells in sputum and fluorescence bronchoscopy using the LIFE Imaging System, and white light bronchoscopy, ID 95 - 230, University of Texas M.D. Anderson Cancer Center, 1996 - 10/98

Collaborator, Phase II Trial of Induction Paclitaxel/Carboplatin in Clinical Stage Ib (T2NO), Stage II (T1 - 2N1), and Selected Stage IIIa (T3NO - 1) Non - small Cell Lung Cancer (NSCLC), ID 96 - 038, University of Texas M.D. Anderson Cancer Center, 1996 - 1999 (Closed)

9


Protocols (cont.)

Collaborator, Phase I Study of Intratumoral E1A Gene Therapy for Patients with Unresectable or Metastatic Solid Tumors that Overexpress HER - 2/new, ID 96 - 117, University of Texas M.D. Anderson Cancer Center, 1996 - 1999 (Closed)

Study Chairperson, A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1 - 2N1, T3N0) and Selected IIIA (T#N1) Non - Small Cell Lung Cancer (NSCLC), ID 99 - 400, University of Texas M.D. Anderson Cancer Center, 1999 - 2004

Collaborator, A Phase II Study of Preoperative 5 - FU, Taxol and Cisplatin Followed by Concurrent 5 - FU/Cisplatin and Radiotherapy in Patients with Potentially Resectable Carcinoma of the Esophagus or GE Junction, ID 96 - 189, University of Texas M.D. Anderson Cancer Center, 1996 - 1998 (Closed)

Collaborator, Phase II Study of Postoperative Adjuvant Therapy in Patients With Completely Resected Stage II and stage IIIa Non - small Cell Lung Cancer (NSCLC), RTOG 97 - 05, University of Texas M.D. Anderson Cancer Center, 1997 - 7/98

Collaborator, A Phase III Intergroup Trial: A Prospective Randomized Comparison of Combined Modality Therapy for Carcinoma of the Esophagus: Chemotherapy Plus Surgery Versus Surgery Alone for Patients with Local Regional Disease, RTOG 89 - 11, University of Texas M.D. Anderson Cancer Center, 1990 - 1995, (Closed)

Co - Principal Investigator, Pilot Study of Combined Approach with Chemotherapy, Radiation Therapy, and Surgery for Advanced Thymoma,. RTOG 90 - 17, University of Texas M.D. Anderson Cancer Center, 1990 - 1992 (Study Closed)

Collaborator, Prospective Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II and Stage IIIa Non - small Cell Lung Cancer, RTOG 91 - 05, University of Texas M.D. Anderson Cancer Center, 1993 - 1996 (Study Closed)

Collaborator, Randomized Phase II Study of Chemotherapy/Radiation Therapy Combination for Favorable Patients with Locally Advanced Inoperable Non - small Cell Lung Cancer, RTOG 92 - 04, University of Texas M.D. Anderson Cancer Center, 1992 - 1994 (Study Closed)

Collaborator, A Phase III Comparison Between Concurrent Chemotherapy Plus Radiotherapy, and Concurrent Chemotherapy Plus Radiotherapy Followed by Surgical Resection for Stage IIIa (N2) Non - small Cell Lung Cancer, RTOG 93 - 09, University of Texas M.D. Anderson Cancer Center, 1994 - 6/02.

Collaborator, A Phase III Intergroup Randomized Comparison of Combined Modality Therapy for Carcinoma of the Esophagus: High Dose vs. Conventional Dose Radiation Therapy, RTOG 94 - 05, University of Texas M.D. Anderson Cancer Center, 1996 - 4/00

Collaborator, A Three Arm Phase III Study of Concomitant vs. Sequential Chemotherapy and Thoracic Radiotherapy for Patients with Locally Advanced Inoperable Non - small Cell Lung Cancer, RTOG 94 - 10, University of Texas M.D. Anderson Cancer Center, 1994 - 8/98

Study Co - Chairman, A Phase III Study of Adjuvant Chemotherapy after Resection for Patients with T2N0 Stage I Non - Small Cell Carcinoma of the Lung, RTOG 96 - 16, University of Texas M.D. Anderson Cancer Center, 1997 - 2004

Collaborator, Phase II Study of Postoperative Adjuvant Therapy in Patients With Completely Resected Stage II and stage IIIa Non - small Cell Lung Cancer (NSCLC), RTOG 97 - 05, University of Texas M.D. Anderson Cancer Center, 1997 - 7/98

Collaborator, Clinical Protocol for Modification on Oncogene and Tumor Suppressor Gene Expression in Non - small Cell Lung Cancer (NSCLC), THS 92 - 001, University of Texas M.D. Anderson Cancer Center, 1992 - 1992 (Closed)

Principal Investigator, A Prospective Evaluation of Video - assisted (Teaching Study) Thoracoscopy (VAT) Techniques in Thoracic Surgery”, THS 92 - 002, University of Texas M.D. Anderson Cancer Center, 1992 - 1992 (Closed)

10


Collaborator, Clinical protocol for modification of mutant K - ras gene expression in non - small cell lung cancer (NSCLC), THS 94 - 001, University of Texas M.D. Anderson Cancer Center, 1995 - 1997 (Closed)

Protocols (cont.)

Collaborator, Clinical Protocol for Modification of Tumor Suppressor Gene Expression and Induction of Apoptosis in Non - small Cell Lung Cancer (NSCLC) with an Adenovirus Vector Expressing Wild - type p53 and Cisplatin, THS 94 - 002, University of Texas M.D. Anderson Cancer Center, 1995 - 1998 (Closed)

Principal Investigator, A Prospective Randomized Study of Pleural Drainage vs. Tube Thoracoscopy and Pleurodesis for Treatment of Pleural Effusions, THS 94 - 003, University of Texas M.D. Anderson Cancer Center, 1994 - 1997 (Closed)

Principal Investigator, A Multicenter Phase III Trial to Evaluate the Efficacy of Recombinant Human GM - CSF (rhu GM-CSF) for Prophylaxis of Postoperative Infection, THS 94 - 004, University of Texas M.D. Anderson Cancer Center, 1994 - 1996 (Closed)

Co-Investigator. Prevention of Death from Adenocarcinoma of the Lung by Low Dose Aspirin, Vanderbilt University Medical Center, 2012.

HONORS AND AWARDS:

Eagle Scout, Boy Scouts of America 1970A. B. with Honors in Chemistry, University of North Carolina at Chapel Hill 1975Sigma Xi Prize for Undergraduate Research, University of North Carolina at Chapel Hill 1975Finalist - The Paul C. Samson Award for Outstanding Resident Manuscript

The Samson Thoracic Surgical Society 1983Outstanding Resident - Surgery, University of Rochester School of Medicine,

Class of 1986 1986Physician’s Recognition Award - American Medical Association 1997 - 2000The Best Doctors in America - Woodward/White, Inc, “Elected by his peers

for inclusion in Best Doctors in America from 1996 to 2011” 1996 - PresentNations’ Top Cancer Specialist for Women 1999Who’s Who in America - Science and Engineering 5th Edition 2000Alley-Sheridan Fellow, “Understanding the New World of Health Care” Harvard University, Boston, MA.; Awarded by The Thoracic Surgery Foundation for Research and Education 2002Houston’s Best Doctors, Inside Houston 2002Teaching Award – The University of Texas – Houston Medical School

“The Surgery Chief Resident Award” 2002Who’s Who in America 2003Margaret W. Elkins Endowment for Research in Thoracic Surgical Oncology 2002 - 2004The Charles and Beverly Adams Fund for Thoracic Surgical Oncology 1998 - 2004

America’s Top Doctors – Castle Connolly 2006 - present2007 Top Scoring Physician – Vanderbilt Medical Group – Surgical Specialty Services,

Overall Quality of Doctor Care (100%) 2007[Based on the Professional Research Consultants, Inc, 2006 National Database]

2008 Top Scoring Clinic [Thoracic Surgery] – Vanderbilt Medical Group – Surgical Specialty Services, Overall Quality of Care (100th percentile) 2008Likelihood to Recommend (100th percentile) 2008[Based on the Professional Research Consultants, Inc., 2007 National Database]

2009 Top Scoring Physician – Vanderbilt Medical Group – Surgical Specialty Services,Overall Quality of Doctor Care (100%) 2009[Based on the Professional Research Consultants, Inc, 2008 National Database]

Five-Star Award for Excellence in Healthcare - Professional Research Consultants Inc. 2010The Charles Adams Fund for Thoracic Surgical Oncology 2008-present

11


PUBLICATIONS:

Articles in Peer-Reviewed Journals

1. Putnam, JB Jr., and Pedersen, L.G. Discovery of a 3’, 5’ - guanosine monophosphate simulating factor in amoebae of Dictyostelium discoideum. Biochim. Biophys. Acta, 411:168 - 170, 1975. PMID:170997

2. Peacock, L.A., Putnam, JB Jr., and Pedersen, LG. Massive body collisions with the solar system. Astronomy Quarterly, 1:16 - 18, 1977.

3. Eslava, L.A., Putnam, JB Jr., and Pedersen, L.G. An ab initio investigation of molecules with a disulfide bond: (HS)2 , (CH3S)2 and cystine. Intl J Peptide Protein Res., 11:149 - 153, 1978. PMID:640773

4. Roth, J.A., Grimm, E.A., Osborne, B.A., Putnam, JB Jr., Davidson, D.D., and Ames, R.S. Suppressive immunoregulatory factors produced by tumors. Lyphokine Res., 2:67 - 73, 1983. PMID:6332246

5. Putnam, JB Jr., Roth, J.A., Wesley, M.N., Johnston, M.R., and Rosenberg, S.A. Survival following aggressive resection of pulmonary metastases form osteogenic sarcoma: analysis of prognostic factors. Ann Thor Surg, 38:516 - 523, 1983. PMID:6579887

6. Putnam, JB Jr., Roth, J.A., Wesley, M.N., Johnston, M.R., and Rosenberg, S.A. Analysis of prognostic factors in patients undergoing resection of pulmonary metastases from soft tissue sarcomas. J Thor Cardiovasc Surg, 87:260 - 267, 1984. PMID:6694417

7. Roth, J.A., Putnam, JB Jr., Wesley, M.N., and Rosenberg, S.A. Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients. Cancer, 55:1361 - 1366, 1985. PMID:3855684

8. Davidson, D.D., Carney, D.N., Putnam, JB Jr., Sugarbaker, P.H., and Roth, J.A. Suppression of murine immunologic functions by fresh and cultured human tumor extracts. J. Surg. Res., 38:289 - 297, 1985. PMID:2984465

9. Putnam, JB Jr., and Roth, J.A. Identification and characterization of a tumor - derived immunosuppressive factor from murine melanoma K-1735. Cancer Immunol. Immunother., 19: 90-100, 1985. PMID:3157440

10. Roth, J.A., Pass, H.I., Wesley, M.N., White, D., Putnam, JB Jr., and Seipp, C. Comparison of median sternotomy and thoracotomy for resection of pulmonary metastases in patients with adult soft tissue sarcomas. Ann Thor Surg, 42:134 - 138, 1986. PMID:3741009

11. Putnam, JB Jr., Lemmer, J.H., Rocchini, A., and Bove, E.L. Embolectomy for acute pulmonary artery occlusion following Fontan procedure. Ann Thor Surg, 45:335 - 336, 1988. PMID:3348707

12. Putnam, JB Jr., Schantz, S.P., Pugh, W.C., Hickey, R.C., Samaan, N.A., Garza, R., and Suda, R.W. Extended en bloc resection of a primary mediastinal parathyroid carcinoma. Ann Thor Surg, 50:138 - 140, 1990. PMID:2369217

13. Murphy, M.C., Sweeney, M.S., Putnam, JB Jr., Walker, W.E., Frazier, O.H., Ott, D.A., and Cooley, D.A. Surgical treatment of cardiac tumors: A 25 - year experience. Ann Thor Surg, 49:612 - 617, 1990. PMID:2322057

14. Putnam, JB Jr., Lammermeier, D.E., Colon, R., McMurtrey, M.J., Ali, M.K., and Roth, J.A. Predicted pulmonary function and survival after pneumonectomy for primary lung carcinoma. Ann Thor Surg, 49:909 - 914, 1990. PMID:2369189

15. Bolling, S.F., Putnam, JB Jr., Abrams, G.D., McKay, A.M., and Deeb, G.M. Hemodynamics versus biopsy during cardiac transplant rejection. Ann Thor Surg, 51:52 - 55, 1991. PMID:1985575

16. Lanza, L.A. *, Putnam, JB Jr., Benjamin, R.S., and Roth, J.A. Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases. Ann Thor Surg, 51:219 - 224, 1991. PMID:1989534

17. Putnam, JB Jr., Bolling, S.F., and Kirsh, M.M. Procainamide-induced respiratory insufficiency following cardiopulmonary bypass. Ann Thor Surg, 51:482 - 483, 1991. PMID:1998432

18. Casson, A.G. *, Putnam, JB Jr., Natarajan, G., Johnston, D.A., Mountain, C., McMurtrey, M., and Roth J.A. Efficacy of pulmonary metastasectomy for recurrent soft - tissue sarcoma. J Surg Oncol 47:1 - 4, May, 1991. PMID: 2023414

19. Putnam, JB Jr., Sweeney, M.S., Colon, R., Lanza, LA, Frazier, O.H., and Cooley, D.A. Primary cardiac sarcomas. Ann Thor Surg, 51:906 - 910, 1991. PMID:2039319

20. Myers, S.I., Harward, T.R., Putnam, JB Jr., and Frazier, O.H. Vascular trauma as a result of therapeutic procedures for the treatment of malignancy. J. Vasc. Surg., 14:314 - 319, 1991. PMID:1880839

* Resident / Fellow: Dr. Putnam served as mentor/faculty advisor*

12

http://www.ncbi.nlm.nih.gov/pubmed/1880839




















Articles in Peer-Reviewed Journals (cont.)

21. Gorenstein, L.A., Putnam, JB Jr., Natarajan, G., Balch, C.A., and Roth, J.A. Improved survival after resection of pulmonary metastases from malignant melanoma. Ann Thor Surg, 52:204 - 210, 1991. PMID:1863140

22. Casson, A.G.*, Putnam, JB Jr., Natarajan, G., Johnston, D.A., Mountain, C., McMurtrey, M., et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer, 69: 661 - 668, 1992. PMID: PMID:1730117

23. Morice, R.C., Peters, E.J., Ryan, M.B., Putnam, JB Jr., Ali, M.K., and Roth, J.A. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest, 101:356 - 361, 1992. PMID: 8418237

24. Gorenstein, L.A.*, and Putnam, JB Jr., Resection of pulmonary metastasis to the azygous lobe from a malignant fibrous histiocytoma. Chest, 101:863 - 865, 1992. PMID:1311667

25. Gauwitz, M., Ellerbroek, N., Komaki, R., Putnam, JB Jr., Ryan, M., and Cundiff, B.S., High dose endobronchial irradiation in recurrent bronchogenic carcinoma. Int. J. Rad. Oncol. Biol. Phys., 23:397 - 400, 1992. PMID:1587762

26. Lanza, L.A.*, Natarajan, G., Roth, J.A., and Putnam, JB Jr., Long - term survival after resection of pulmonary metastases from carcinoma of the breast. Ann Thor Surg, 54:244 - 248, 1992. PMID:1637212

27. Cybulsky, I.J., Lanza, L.A., Ryan, M.B., Putnam, JB Jr., McMurtrey, M.J., and Roth, J.A. Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thor Surg, 54:533 - 537, 1992. PMID:1324657

28. Shin, D.M., El - Naggar, A.K., Putnam, JB Jr., Komaki, R., and Hong, W.K. Pathologic remission of invasive thymoma after induction chemotherapy. Case Report, Cancer Bull., 44:346 - 348, 1992.

29. Pollack, A., Komaki, R., Cox, J.D., Ro, J.Y., Oswald, M.J., Shin, D.M., and Putnam, JB Jr., Thymoma: Treatment and prognosis. Int. J. Radiat. Oncol. Biol. Phys., 23:1037 - 1043, 1992. PMID:1639638

30. Ajani, J.A., Roth, J.A., Ryan, M.B., Putnam, JB Jr., Pazdur, R., Levin, B., Gutterman, J.U., and McMurtrey, M. Intensive preoperative chemotherapy with colony stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J. Clin. Oncol. 11:22 - 28, 1993. PMID: 8418237

31. Putnam, JB Jr., Suell, D.M., Roth, J.A., and Natarajan, G. Extended resection of pulmonary metastases: Is the risk justified? Ann Thor Surg, 55:1440 - 1446, 1993. PMID:8512393

32. Sella, A., Swanson, D.A., Ro, J.Y., Putnam, JB Jr., Amato, R.J., Markowitz, A.V., and Logothetis, C.J. Surgery following response to interferon - based therapy for residual renal cell carcinoma. J. Urol., 149:19 - 21, 1993. PMID:8417208

33. Putnam, JB Jr., Suell, D.A., McMurtrey, M.J., Ryan, M.B., Walsh, G.L., Natarajan, G., and Roth, J.A. Comparison of three techniques of esophagectomy within a residency training program. Ann Thor Surg, 57:319 - 325, 1994. PMID:8311591

34. Park, H.S., Shin, D.M., Komaki, R., Lee, J.S., Pollack, A., and Putnam, JB Jr., Thymoma: A retrospective study of 87 cases. Cancer, 73:2491 - 2498, 1994. PMID: 8174044

35. Putnam, JB Jr., Dignani, C., Mehra, R.C., Anaissie, E.J., and Morice, R.C. Acute airway obstruction and necrotizing tracheobronchitis form invasive mycosis. Chest, 106:1265 - 1267, 1994. PMID:7924508Walsh, G.L., Morice, R.C., Putnam, JB Jr., Nesbitt, J.C., McMurtrey, M.J., Ryan, M.B., Reising, J., Willis, K.M., Morton, J.D., and Roth, J.A. Resection of lung cancer is justified in high risk patients selected by exercise oxygen consumption. Lung Cancer: 12: 301, 1995. PMID:7944692

36. Roth, J.A., Fossella, F., Komaki, R., Ryan, M.B., Putnam, JB Jr., Lee, J.S., Dhingra, H., DeCaro, L., Chason, M., McGavran, M., Atkinson, E.N., and Hong, W.K. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non - small cell lung cancer. J. Natl. Cancer Inst., 86:673 - 680, 1994. PMID:8158698

37. Ajani, J.A., Roth, J.A., Putnam, JB Jr., Walsh, G.L., Lynch, P.M., Roubein, L.D., Ryan, M.B., Natarajan, G., and Gould, P. Feasibility of five courses of preoperative chemotherapy in patients with resectable adenocarcinoma of the esophagus or gastroesophageal junction. Euro. J. Cancer, 31A:665 - 670, 1995. PMID: 7640036

38. Nesbitt, J.C., Putnam, JB Jr., Walsh, G.L., Roth, J.A., and Mountain, C.F. Survival in early stage non - small cell lung cancer. Ann Thor Surg, 60:466 - 472, 1995. PMID:7646126

39. Soysal, O. *, Walsh, G.L., Nesbitt, J.C., McMurtrey, M.J., Roth, J.A., and Putnam, JB Jr., Resection of sternal tumors: extent, reconstruction, and survival. Ann Thor Surg, 60:1353 - 1359, 1995. PMID:8526626

** Resident / Fellow: Dr. Putnam served as mentor/faculty advisor 13





http://www.ncbi.nlm.nih.gov/pubmed?term=Resection%20of%20lung%20cancer%20is%20justified%20in%20high%20risk%20patients%20selected%20by%20exercise%20oxygen%20consumption





http://www.ncbi.nlm.nih.gov/pubmed?term=Extended%20resection%20of%20pulmonary%20metastases%3A%20Is%20the%20risk%20justified%3F













40. Walsh, G.L., O’Conner, M., Willis, K.M., Milas, M., Wong, R.S., Nesbitt, J.C., Putnam, JB Jr., Lee, J., and Roth, J.A. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thor Surg, 60:1563 - 1570, 1995. PMID:8787445

41. Roth, J.A., Nguyen, D., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., Ferson, D.Z., Hong, W.K., Komaki, R., Lee, J.J., Nesbitt, J.C., Pisters, K.M.W., Putnam, JB Jr., Shea, R., Shin, D.M., Walsh, G.L., Dolormente, N.N., Han, C - I., Martin, F.D., Yen, N., Stephens, L.C., McDonnell, T.J., Mukhopadhyay, T., and Cai, D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat. Med., 2:985 - 991, 1996. PMID: 8782455

42. Tanguay S.* Swanson, D.A., and Putnam, JB Jr.. Renal cell carcinoma metastatic to the lung: potential benefit of the combination of biological therapy and surgery. J. Urol. 156:1586 - 1589, 1996. PMID:8863544

43. Roth, J.A., Beech, D.J., Putnam, JB Jr., Pollock, R.E., Pate, S.R., Fidler, I.J., and Benjamin, R.S. Treatment of the patient with lung metastases, Curr. Probl. Surg., 33:881-952, 1996. PMID: 8909328

44. Perkins, P., Kemp, B.L., Putnam, JB Jr., and Cox, J.D.. Pretreatment characterization of carcinoid tumors of the lung which predict aggressive behavior. Am. J. Clin. Oncol., 20:285 - 88, 1997. PMID:9167755

45. Pastorino, U., Buyse, M., Friedel, G., Ginsberg, R.J., Goldstraw, P., Johnston, M., McCormack, P., Pass, H., and Putnam, JB Jr. Long-term results of lung metastasectomy: prognostic analyses based on 5,206 cases. J Thor Cardiovasc Surg, 113:37 - 49, 1997. PMID:9011700

46. Ferson, D.Z., Nesbitt, J.C., Nesbitt, K.K., Walsh, G.L., Putnam, JB Jr., Schrump, D.S., Johansen, M.J., Jones, R.L., and Roth, J.A. The laryngeal mask airway: A new standard for airway evaluation in thoracic surgery. Ann Thor Surg, 63:768 - 772, 1997. PMID:9066399

47. Walsh, G.L., Gokaslan, Z.L., McCutheon, I.E., Mineo, M.T., Yosko, A., Swisher, S.G., Schrump, D.S., Nesbitt, J.C., Putnam, JB Jr., and Roth, J.A. Anterior approaches to the thoracic spine in patients with cancer: Indications and results. Ann Thor Surg, 64:1611 - 1618, 1997. PMID:9436544

48. Nesbitt, J.C., Soltero, E.R., Dinney, C.P.N., Walsh, G.L., Schrump, D.S., Swanson, D.A., Pisters, L.L., Willis, K.D., and Putnam, JB Jr.. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thor Surg, 63:1592 - 1600, 1997. PMID:9205155

49. Perry, M.C., Deslauriers, J., Albain, K.S., Choi, N.C., Depierre, A., Johnston, M.R., et al. Induction treatment for resectable non-small-cell lung cancer. Lung Cancer 17: Suppl - 8: S15 - S18, 1997. PMID: 9213297

50. Leukine Surgical Prophylaxis Research Group [Putnam, JB Jr., (P.I., UT M. D. Anderson Cancer Center]. Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. J. Clin. Oncol. 16:1167 - 1173, 1998. PMID: 9508204

51. Shin, D.M., Walsh, G.L., Komaki, R., Putnam, JB Jr., Nesbitt, J., Ro, J.Y., Shin, H.J., Ki, K.H., Wimberly, A., Pisters, K.M., Schrump, D., Gregurich, M.A., Cox, J.D., Roth, J.A., and Hong, W.K. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann. Intern. Med., 129:100 - 4, 1998. PMID: 9669967

52. Gokaslan, Z.L., York, J.E., Walsh, G.L., McCutcheon, I.E., Lang, F.F., Putnam, JB Jr., Wildrick, D.M., Swisher, S.G., Abi - Said, D., Sawaya, R. Transthoracic vertebrectomy for metastatic spinal tumors. J. Neurosurg., 89: 599 - 609, 1998. PMID:9761054

53. Roth, J.A., Atkinson, E.N., Fossella, F., Komaki, R., Ryan, M.B., Putnam, JB Jr., Lee, J.S., Dhingra, H., De Caro, L., Chasen, M., and Hong, W.K. Long-term follow-up of patients enrolled in a randomized trialcomparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer. Lung Cancer, 21:1 - 6, 1998. PMID:9792048

54. Swisher, S.G., Nemunaitis, J., Timmons, T., Connors, D., Mack, M., Doerksen, L., Savin, M., Weill, D., Shulkin, A., Wait, J., Ognoskie, N., Lawrence, D.D., Kemp, B.L., Fossella, F., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.M., Lee, J.J., Lee, J.S., Nguyen, D.M., Nesbitt, J.C., Perez - Soler, R., Pisters, K.M.W., Putnam, JB Jr., Richli, W.R., Shin, M.D.M., Walsh, G., Merritt, J., and Roth, J.A. Adenovirus-mediated p53 gene transfer in advanced non-small cell lung cancer. J. Natl. Cancer Inst., 91: 763 - 771, 1999. PMID:10328106

55. Putnam, JB Jr., Light R.W., Rodriguez, R.M., Ponn, R., Olak, J., Pollak, J.S., and Lee, R.B. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer, 86:1992 - 9, 1999. PMID:10570423

56. Gandhi, S., Walsh, G.L., Komaki, R., Gokaslan, Z.L., Nesbitt, J.C., Putnam, JB Jr., Roth, J.A., Merriman, K.W., McCutcheon, I.E., Munden, R.F., and Swisher, S.G. A multidisciplinary surgical approach to superior

14







http://www.ncbi.nlm.nih.gov/pubmed?term=Randomized%2C%20placebo-controlled%2C%20multicenter%20trial%20of%20granulocyte-macrophage%20colony-stimulating%20factor%20as%20infection%20prophylaxis%20in%20oncologic%20surgery






http://www.ncbi.nlm.nih.gov/pubmed?term=Long-term%20results%20of%20lung%20metastasectomy%3A%20prognostic%20analyses%20based%20on%205%2C206%20cases


http://www.ncbi.nlm.nih.gov/pubmed?term=Durr.%20Probl.%20Surg.%2C%2033%3A881-952%2C%201996




Joe B. Putnam, Jr., M.D. Rev. December 2012sulcus tumors with vertebral invasion. Ann Thor Surg, 68:1778 - 84; discussion 1784-5, 1999. PMID:10585058


57. Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB Jr, Richli WR, Savin M, Schrump DS, Shin DM, ShulkinA, Walsh GL, Wait J, Weill D, Waugh MK. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst. 1999 May 5;91(9):763-71. PMID:10328106

58. York, J.E., Walsh, G.L., Lang, F.F., Putnam, JB Jr., McCutcheon, I.E., Swisher, S.G., Komaki, R., and Gokaslan, Z.L. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. J Neurosurg 91:74 - 80, 1999. PMID: 10419372

59. Zebrowski, B.K. *, Yano, S., Liu, W., Hicklin, D.J., Putnam, JB Jr., and Ellis, L.M. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin. Cancer Res., 5:3364 - 68, 1999. PMID:10589746

60. Friedel G., Pastorino, U., Buyse, M., Ginsberg, R.J., Girard P., Goldstraw P. Putnam, JB Jr., et al. Resection of lung metastases: long - term results and prognostic analysis based on 5206 cases – the International Registry of Lung Metastases. (German). Zentralblatt fur Chirurgie, 124: 96 - 103, 1999. PMID: 10419372

61. Medgyesy, D.C., Wolff, R.A., Putnam, JB Jr., and Ajani, J.A. Small cell carcinoma of the esophagus: The University of Texas M.D. Anderson Cancer Center Experience and Literature Review. Cancer, 88:262 - 267, 2000. PMID:10640955

62. Putnam, JB Jr., Walsh, G.L., Swisher, S.G., Roth, J.A., Suell, D., Vaporciyan, A.A., Smythe, W.R., Merriman, K.W., and DeFord, L.L. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thor Surg, 69: :369 - 75, 2000. PMID:10735665

63. Pisters, K., Ginsberg, R., Giroux, D., Kris, M., Putnam, JB Jr., Roberts, J. R., Johnson, D. H., Crowley, J., and Bunn, P. Induction chemotherapy before surgery for early stage lung cancer - A novel approach. Bimodality Lung Oncology Team, J Thor Cardiovasc Surg, 119:429 - 39, 2000. PMID:10694600

64. Nemunaitis, J., Swisher, S.G., Timmons, T., Connors, D., Mack, M., Doerksen, L., Weill, D., Wait, J., Lawrence, D.D., Kemp, B.L., Fossella, F., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.M., Lee, J.J., Lee, J.S., Nguyen, D.M., Nesbitt, J.C., Perez - Soler, R., Pisters, K.M.W., Putnam, JB Jr., Richli, W.R., Shin, D.M., Walsh, G.L., Merritt, J., and Roth, J.A. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small cell lung cancer. J. Clin. Oncol., 18:609-622, 2000. PMID:10653876

65. Yen, N., Ioannides, C.G., Xu, K., Swisher, S.G., Lawrence, D.D., Kemp, B.L., El - Naggar, A.K., Cristiano, R.J., Fang, B., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.M., Lee, J.J., Lee, J.S., Merritt, J.A., Mukhopadhyay, T., Nesbitt, J.C., Nguyen, D., Perez - Soler, R., Pisters, K.M.W., Putnam, JB Jr., Schrump, D.S., Shin, D.M., Walsh, G.L., and Roth J.A. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild - type p53 (Ad - p53). Cancer Gene Therapy, 7: 530-536, 2000. PMID:10811470

66. Swisher, S.G., DeFord, L., Merriman, K.W., Walsh, G.L., Smythe, W.R., Vaporciyan, A.A., Ajani J.A., Brown, T., Komaki, R., Roth, J.A., and Putnam, JB Jr.. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thor Cardiovasc Surg, 119:1126 - 1132, 2000. PMID: 10838528

67. Komaki, R., Roth, JA Walsh, G.L., Putnam, JB Jr., Vaporciyan A, Lee JS, Fossella FV, Chasen M, Delclos ME, Cox JD. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at The University of Texas M. D. Anderson Cancer Center. Int. J. Radiat. Oncol. Biol. Phys., 2000 Sep 1; 48(2): 347-54. PMID: 10974447

68. Putnam, JB Jr., Thomsen, S.L., and Siegenthaler, M. Therapeutic implications of heat-induced lung injury: matching the energy source to the clinical need: Critical Review, 75:139 - 160, 2000.

69. Walsh, G.L., Davis, B.M., Swisher, S.G., Vaporciyan, A.A., Smythe, W.R., Merriman, K.W., Roth, J.A., and Putnam, JB Jr. A single-institutional multidisciplinary approach to primary sarcomas involving the chest wall requiring full thickness resections. J. Thorac. Cardio. Surg., 121:48 - 60, 2001. PMID:11135159

70. Schnirer, I.I., Komaki, R., Yao, J.C., Swisher, S.G., Putnam, JB Jr., Pisters, P.W.T., Roth, J.A., and Ajani, J.A. A pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction. Am. J. Clinic. Oncol., 24:91 - 95, 2001. PMID:11232959


http://www.ncbi.nlm.nih.gov/pubmed?term=Pilot%20study%20of%20concurrent%205-fluorouracil%2Fpaclitaxel%20plus%20radiotherapy%20in%20patients%20with%20carcinoma%20of%20the%20esophagus%20and%20gastroesophageal%20junction

http://www.ncbi.nlm.nih.gov/pubmed?term=A%20single-institutional%20multidisciplinary%20approach%20to%20primary%20sarcomas%20involving%20the%20chest%20wall%20requiring%20full%20thickness%20resections





http://www.ncbi.nlm.nih.gov/pubmed?term=Adenovirus-mediated%20p53%20gene%20transfer%20in%20sequence%20with%20cisplatin%20to%20tumors%20of%20patients%20with%20non-small%20cell%20lung%20cancer










Joe B. Putnam, Jr., M.D. Rev. December 201271. Smythe, W.R., Estrera, A.L., Swisher, S.G., Roth, J.A., Merriman, K.W., Walsh, G.L., Putnam, JB Jr.,

Vaporciyan, A.A., and Roth, J.A. Surgical resection of non - small cell carcinoma following treatment for small cell carcinoma. Ann Thor Surg, 71:962 - 966, 2001. PMID:11269481


72. Siegenthaler, M.P. *, Pisters, K.M., Merriman, K.W., Swisher, S.G., Roth, J.A., Walsh, G.L., Vaporciyan, A.A., Smythe, W.R., and Putnam, JB Jr.. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thor Surg, 71:1105 - 1112, 2001. PMID:11308144

73. Walsh G.L., Davis, B.M., Swisher, S.G., Vaporciyan A.A., Smyth W.R., Willis - Merriman K., Roth J.A., Putnam, JB Jr.. A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections. J Thorac Cardiovasc Surg 121: 48 - 60, January 2001. PMID:11135159

74. Ajani, J.A., Komaki, R., Putnam, JB Jr., Walsh, G., Nesbitt, J., Pisters, P.W., Lynch, P.M., Vaporciyan, A., Smythe, R., Lahoti, S., Raijman I., Swisher, S., Martin, F.D., and Roth, J.A. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer, 92:279 - 286, 2001. PMID: 11466680

75. Hortobagyi, G.N., Ueno, N.T., Xia, W., Zhang, S., Wolf, J.K., Putnam, JB Jr., Weiden, P.L., Willey, J.S., Carey, M., Branham, D.L., Payne, J.Y., Tucker, S.D., Bartholomeusz, C., Kilbourn, R.G., DeJager, R.L., Sneige, N., Katz, R.L., Anklesaria, P., Ibrahim, N.K., Murray, J.L., Theriault, R.L., Valero, V., Gershenson, D.M., Bevers, M.W., Huang, L., Lopez - Berestein, G., and Hung, M.C. Cationic Liposome - mediated E1A gene transfer to human breast and ovarian cancer cells and its biological effects: A phase I clinical trial. J. Clin. Oncol., 19:3422 - 3433, 2001. PMID: 11454891

76. Lewin, J.S., Hebert, T.M., Putnam, JB Jr., and DuBrow, R.A. Experience with the maneuver in post esophagectomy aspirators. Dysphagia, 16:216 - 219, 2001. PMID:11453570

77. Komaki, R., Chasen, M.H., Travis, W.D., Putnam, JB Jr., Fossella, F.V., Byhardt, R.W., and Ro, J.Y. Oncodiagnosis panel: 1999, Cancer of the lung: Oncodiagnosis. Radiographics, 21:1573 - 1596, 2001. PMID: 11706227

78. Wang, X., Wang. L., Callister, M.D., Putnam, JB Jr., Mao, L., and Li, L. Human Rad17 is phosphorylated upon DNA damage and also overexpressed in primary non - small cell lung cancer tissues. Cancer Res., 61:7417 - 7421, 2001. PMID: 11606373

79. Vaporciyan, A.A., Merriman, K.W., Ece, F., Roth, J.A., Smythe, W.R., Swisher, S.G., Walsh, G.L., Nesbitt, J.C., and Putnam, JB Jr. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thor Surg 73: 420 - 425, 2002. PMID:11845853

80. Rice, D.C., and Putnam, JB Jr. Recurrent bronchogenic cyst causing recurrent laryngeal nerve palsy. Eur. J. Cardiothorac. Surg., 21:561 - 563, 2002. PMID:11888786

81. Swisher, S.G., Wynn, P., Putnam, JB Jr., Mosheim, M.B., Correa, A.M., Komaki, R.R., Ajani, J.A., Smythe, W.R., Vaporciyan, A.A., Roth, J.A., and Walsh, G.L. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thor Cardiovasc Surg, 123:175 - 183, 2002. PMID: 11782772

82. Vaporciyan, A.A., Rice, D.D., Correa, A.M., Walsh, G.L., Putnam, JB Jr., Swisher, S.G., Smythe, W.R., and Roth, J.A. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Eur. J. Cardiothorac. Surg., 22:47 - 52, 2002. PMID: 12103372

83. Bubb, R.S., Komaki, R., Hachiya, T., Milas, I., Ro, J.Y., Langford, L., Sawaya, R., Putnam, JB Jr., Allen, P., Cox, J.D., McDonnell, T.J., Brock, W., Hong, W.K., Roth, J.A., and Milas, L. Association of Ki-67, p53, and bcl-2 expression of the primary non-small cell lung cancer lesion with brain metastatic lesion. Int. J. Radiat. Oncol. Biol. Phys., 53: 1216 - 1224, 2002. PMID: 12128123

84. Friedel, G., Pastorino, U., Ginsberg, R. J., Goldstraw, P., Johnston, M., Pass, H., Putnam, J. B., Toomes, H., and International Registry of Lung Metastases, London England. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. European Journal of Cardio - Thoracic Surgery. 22:335 - 344. 2002. PMID: 12204720

85. Hofstetter, W., Swisher, S.G., Correa, A.M., Hess, K., Putnam, JB Jr., Ajani, J.A., Dolormente, M., Francisco, R., Komaki, R.R., Martin, L.A., Rice, D.C., Sarabia, A.J., Smythe, W.R., Vaporciyan, A.A., Walsh, G.L., and Roth, J.A. Treatment outcomes of resected esophageal cancer. Ann. Surg., 236:376 - 384; discussion 384-385, 2002. PMID:12192324

86. Swisher, S. G., Roth, J. A., Komaki, R., Gu, J., Lee, J. J., Hicks, M., RO, J. Y., Hong, W. K., Merritt, J. A., Ahrar, K., Atkinson, N. E., Correa, A. M., Dolormente, M., Dreiling, L., el Naggar, A. K., Fossella, F.,

















http://www.ncbi.nlm.nih.gov/pubmed?term=Siegenthaler%20MP%2C%20Pisters%20KM%2C%20Merriman%20KW%2C%20Roth%20JA%2C%20Swisher%20SG%2C%20Walsh%20GL%2C%20Vaporciyan%20AA%2C%20Smythe%20WR%2C%20Putnam%20JB%20Jr.


Joe B. Putnam, Jr., M.D. Rev. December 2012Francisco, R., Glisson, B., Grammer, S., Herbst, R., Huaringa, A., Kemp, B., Khuri, F. R., Kurie, J. M., Liao, Z., McDonnell, T. J., Morice, R., Morello, F., Munden, R., Papadimitrakopoulou, V., Pisters, K. M., Putnam, J. B., Jr., Sarabia, A. J., Shelton, T., Stevens, C., Shin, D. M., Smythe, W. R., Vaporciyan, A. A., Walsh, G. L., and Yin, M. Induction of p53 - regulated genes and tumor regression in lung cancer patients after


Intra-tumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clinical Cancer Research. 9[1], 93 - 101. 2003. PMID:12538456

87. Swisher, S. G., Ajani, J. A., Komaki, R., Nesbitt, J. C., Correa, A. M., Cox, J. D., Lahoti, S., Martin, F., Putnam, J. B., Smythe, W. R., Vaporciyan, A. A., Walsh, G. L., and Roth, J. A. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for loco-regionally advanced esophageal cancer. International Journal of Radiation Oncology, Biology, and Physics. 57: 120 - 127, 2003. PMID: 12909224

88. Sabloff B, Munden RF, Melhem AI, el Naggar AK, Putnam, JB Jr., Jr. Radiologic-pathologic conferences of University of Texas M. D. Anderson Cancer Center: Extraskeletal osteosarcoma of the pleura. American Journal of Roentgenology, 180:972, 2003. PMID:12646438

89. Rice, D., Kim, H. W., Sabichi, A., Lippman, S., Lee, J. J., Williams, B., Vaporciyan, A., Smythe, W. R., Swisher, S., Walsh, G., Putnam, J. B., Jr., Hong, W. K., and Roth, J. The risk of second primary tumors after resection of stage I non - small cell lung cancer. Annals of Thoracic Surgery, 76:1001 - 1007, 2003. PMID:14529975

90. Milas, I., Komaki, R., Hachiya, T., Bubb, R. S., Ro, J. Y., Langford, L., Sawaya, R., Putnam, J. B., Allen, P., Cox, J. D., McDonnell, T. J., Brock, W., Hong, W. K., Roth, J. A., and Milas, L. Epidermal growth factor receptor, cyclooxygenase - 2, and BAX expression in the primary non - small cell lung cancer and brain metastases. Clinical Cancer Research 9:1070 - 1076, 2003. PMID: 12631609

91. Sweeney, P., Wood, C.G., Pisters, L.L., Slaton, J.W., Vaporciyan A., Munsell, M., Putnam, J.B. Jr. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urologic Oncology 21: 327 - 33, 2003. PMID:14670538

92. Lee, H. K., Vaporciyan, A. A., Cox, J. D., Tucker, S. L., Putnam, J. B., Jr., Ajani, J. A., Liao, Z., Swisher, S. G., Roth, J. A., Smythe, W. R., Walsh, G. L., Mohan, R., Liu, H. H., Mooring, D., and Komaki, R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose - volume histogram parameters. International Journal of Radiation Oncology, Biology, Physics 57:1317 - 1322, 2003. PMID:14630268

93. Sabloff B, Munden RF, Melhem AI, El-Naggar AK, Putnam JB Jr. Radiologic-pathologic conferences of the University of Texas M. D. Anderson Cancer Center: Extraskeletal osteosarcoma of the pleura. AJR Am J Roentgenol. 2003 Apr;180(4):972. PMID:12646438

94. Tsao AS, McDonnell T, Lam S, Putnam, JB Jr., Bekele N, Hong WK, Kurie JM. Increased phospho-AKT (Ser 473) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer Epidemiol Biomarkers Prev. Jul; 12:660 - 4, 2003. PMID: 12869408

95. Taylor NA, Liao ZX, Stevens C, Walsh G, Roth J, Putnam JB Jr, Fossella F, Allen P, Cox JD, Komaki R. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small cell lung cancer treated with induction chemotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 56:616 - 25, 2003. PMID:12788166

96. Sweeney P, Wood CG, Pisters LL, Slaton JW, Vaporciyan A, Munsell M, Carpenter S, Putnam, JB Jr., Swisher SG, Walsh G, Swanson D, Dinney CP. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol. 21:327 - 33, 2003. PMID: 14670538

97. Eberhardt WE, Albain KS, Pass H, Putnam, JB Jr., Gregor A, Asamura H, Mornex F, Senan S, Belderbos J, Westeel V, Thomas M, Van Schil P, Vansteenkiste J, Manegold C, Mirimanoff RO, Stuschke M, Pignon J, Rocmans P, Shepard FA. Induction treatment before surgery for non-small cell lung cancer. Lung Cancer. 2003 Dec; 42 Suppl 1: S9 – 14 Review. PMID:14708516

99. Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, Chang JY, Guerrero T, Jeter M, Putnam J Jr., Fossella FV, Allen P, Komaki R. Equivalent outcome of patients with clinical stage IIIA non - small - cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. Int J Radiat Oncol Biol Phys. 58: 204 - 12, 2004. PMID:14697440

100. Onn A, Correa Am, Gilcrease M, Isobe T, Massarelli E, Bucanna CD, O’Reilly MS, Hong WK, Fidler IJ, Putnam, JB Jr., Herbst RS. Synchronous overexpression of epidermal growth factor receptor and HER2 - neu protein is a predictor of poor outcome in patients with state I non - small cell lung cancer. Clin Cancer Res. 10: 136 - 43, 2004. PMID: 14734462

17





http://www.ncbi.nlm.nih.gov/pubmed?term=Postoperative%20radiotherapy%20increases%20locoregional%20control%20of%20patients%20with%20stage%20IIIA%20non-small-cell%20lung%20cancer%20treated%20with%20induction%20chemotherapy%20followed%20by%20surgery







http://www.ncbi.nlm.nih.gov/pubmed?term=Radiologic-pathologic%20conferences%20of%20the%20University%20of%20Texas%20M.%20D.%20Anderson%20Cancer%20Center%3A%20Extraskeletal%20osteosarcoma%20of%20the%20pleura.




Joe B. Putnam, Jr., M.D. Rev. December 2012101. Vaporciyan AA, Putnam, JB Jr., Smythe WR. The potential role of aprotinin in the perioperative

management of malignant tumors. J Am Coll Surg. 198: 266 - 78, 2004. PMID:14759785102. Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam, JB Jr., Risk

factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg. 127:779 - 86, 2004. PMID:15001907


103. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam, JB Jr., Lynch PM, Wu TT, Smythe WR, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with loco-regional carcinoma of the esophagus or gastroesophageal junction. Cancer 100:2347-54, 2004. PMID:15160337

104. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam, JB Jr., Abu - Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol. 99:1258 - 66, 2004. PMID:15233663

105. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam, JB Jr., Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int. J Radiat Oncol Biol Phy 60: 427 - 36, 2004. PMID:15380576

106. Swisher SG, Eramus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam, JB Jr., Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer. 101:1776 - 85, 2004. PMID:15386332

107. Vaporciyan, A.A., Merriman, K.W., Ece, F., Roth, J.A., Smythe, W.R., Swisher, S.G., Walsh, G.L., Nesbitt, J.C., and Putnam, JB Jr. Utility of PET, CT and EUS to identify pathologic responders in esophageal cancer. Ann Thor Surg, 78:1152 - 60, 2004. PMID: 15464463

108. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Steven SW, Ho L, Smythe R, Vaporciyan AA, Putnam, JB Jr., Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys. 60:1484 - 93, 2004. PMID:15590179

109. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB Jr, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA.Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer. 2004 Jun 1;100(11):2347-54. PMID:15160337

110. Newman, L.A., Hurd, T., Leitch, M., Kuerer, H.M., Diehl, K., Lucci, A., Putnam, JB Jr., et al. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. J Am Coll Surgeons 4: 644 - 51, 2004. PMID:15454152

111. Swisher, S.G., Maish, M., Erasmus, J.J., Correa, A.M., Ajani, J.A., Bresalier, R., Putnam, JB Jr. Utility of PET, CT and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78: 1152 - 60, 2004. PMID:15464463

112. Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB Jr, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer. 2004 Oct 15;101(8):1776-85. PMID:15386332

113. Kim ES, Putnam, JB Jr., Jr., Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer. 44:369 - 79, 2005. PMID: 15140551

114. Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam, JB Jr., Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thor Surg; 79:391 - 7, 2005. PMID:15680801

115. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam, JB Jr., Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD. [18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small cell lung cancer. J Clin Oncol. 23:1136 - 43, 2005. PMID: 15718309

18





http://www.ncbi.nlm.nih.gov/pubmed?term=Utility%20of%20PET%2C%20CT%20and%20EUS%20to%20identify%20pathologic%20responders%20in%20esophageal%20cancer

http://www.ncbi.nlm.nih.gov/pubmed?term=A%20report%20on%20accrual%20rates%20for%20elderly%20and%20minority-ethnicity%20cancer%20patients%20to%20clinical%20trials%20of%20the%20American%20College%20of%20Surgeons%20Oncology%20Group







http://www.ncbi.nlm.nih.gov/pubmed?term=Preoperative%20induction%20of%20CPT-11%20and%20cisplatin%20chemotherapy%20followed%20by%20chemoradiotherapy%20in%20patients%20with%20loco-regional%20carcinoma%20of%20the%20esophagus%20or%20gastroesophageal%20junction.%20Cancer%20100%3A2347-54%2C%202004



Joe B. Putnam, Jr., M.D. Rev. December 2012116. Shaw AD, Vaporciyan AA, Wu X, King TM, Spitz MR, Putnam, JB Jr., Dickey BF. Inflammatory gene

polymorphisms influence risk of postoperative morbidity after lung resection. Ann Thor Surg. 2005 May; 79: 1704 - 10. PMID: 15854959

117. Gaspar, LE, Gay EG, Crawford J, Putnam JB Jr, Herbst RS, Bonner JA. Limited-stage small-cell lung cancer (Stages (I - III): Observations from the National Cancer Database. Clin Lung Cancer. 2005 May; 6: 355-60. PMID: 15943896


118. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam, JB Jr, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thor Cardiovasc Surg 2005 Nov; 130:1391-8. PMID:16256794

119. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Jr., Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non - small cell lung cancer over 16 years at a single institution. J Thor Cardiovasc Surg 130:1601 - 10, 2005. PMID:16308005

120. Allen MS, Darling GE, Pechet TT, Mitchell JD, Herndon JE, Landreneau RJ, Inculet RI, Jones DR, Meyers BF, Harpole DH, Putnam JB, Jr., Rusch VW, and ACOSOG Z0030 Study Group. Morbidity and mortality of major pulmonary resections in patients with early - stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thor Surg; 81: 1013 - 1020, 2006. PMID:16488712

121. Posther, K.E., McCall, L.M., Harpole, D.H., Jr., Reed, C.E., Putnam JB Jr., Rusch, V.W., et al. Yield of brain 18F - FDG PET in evaluating patients with potentially operable non - small cell lung cancer. Journal of Nuclear Medicine 47: 1607 - 11, 2006. PMID:17015895

122. Albert, JM, Gonzalez, A, Massion, PP, Chen, H, Olson, SJ, Shyr, Y, Diaz, R, Lambright, ES, Sandler, A, Carbone, DP, Putnam, JB Jr., Johnson, DH, Lu, B. Cytoplasmic Clusterin Expression is Associated with Longer Survival in Patients with Resected Non - Small Cell Lung Cancer. Cancer Epidemiol Biomarkers Prev 2007; 16, 1845 - 51, 2007. PMID:17855704

123. Horn, L., Sandler, A.B., Putnam, J.B., Jr., Johnson, D.H. The rationale for adjuvant chemotherapy in stage I non - small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2: 377 - 383, 2007. PMID:17473651

124. Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, Swisher SG, Roth JA, Huh J, Chu D, Smythe WR. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg. 2007 Sep;84(3):982-6. PMID:17720413.

125. Meyers, BF, Downey, RJ, Decker, PA, Keenan, RJ, Siegel, BA, Cerfolio, RJ, Landreneau, RJ, Reed, CE, Balfe, DM, Dehdashti, F, Ballman, KV, Rusch, VW, Putnam, JB Jr. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 133: 738 - 745, 2007. PMID:17320575

126. Kozower BD, Meyers CG, Reed CE, Jones DR, Decker PA, Putnam JB Jr. Does positron emission tomography prevent Nontherapeutic pulmonary resections for clinical stage IA lung cancer? Ann Thorac Surg; 85: 1166 – 1169 (discussion 1169 – 1170), 2008. PMID:18355490

127. Veeramachaneni NK, Zoole JB, Decker PA, Putnam JB, Jr., Meyers BF, American College of Surgeons Oncology Group. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial. Annals of Thoracic Surgery 421 20; 86(2):418-21. PMID:18640307

128. Wakelee H. Kernstine K. Vokes E. Schiller J. Baas P. Saijo N. Adjei A. Goss G. Gaspar L. Gandara DR. Choy H. Putnam JB Jr. Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer. Clinical Lung Cancer 2008 Nov; 9(6):346-51. PMID:19073517

129. Blackmon SH. Rice DC. Correa AM. Mehran R. Putnam JB Jr. Smythe WR. Walkes JC. Walsh GL. Moran C. Singh H. Vaporciyan AA. Reardon M. Management of primary pulmonary artery sarcomas. Annals of Thoracic Surgery 2009 Mar; 87(3):977-84. PMID:19231448

130. Wakelee H, Loo BW Jr, Kernstine KH, Putnam JB Jr., Edelman MJ, Vokes EE, Schiller JH, Baas P, Saijo N, Adjei A, Goss G, Choy H, Gandara DR. Cooperative Group Research Efforts in Thoracic Malignancies 2009: A Review from the 10th Annual International Lung Cancer Congress. Clinical Lung Cancer 2009 Nov; 395-404. PMID:19900856

131. Moretti L, Yu DS, Chen H, Carbone DP, Johnson DH, Keedy VL, Putnam JB Jr, Sandler AB, Shyr Y, Lu B. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy. Oncologist. 2009 Nov;14(11):1106-15. PMID:19897534

19

















Joe B. Putnam, Jr., M.D. Rev. December 2012132. Pisters KMW, Vallieres E, Crowley JJ, Franklin WA, Bunn PA, Ginsberg RJ; Putnam JB Jr, Chansky K,

Gandara DR. Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non-Small Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial. Journal of Clinical Oncology, April 10, 2010: 1843-1849. PMID:20231678

133. Scott WJ, Allen MS, Darling G, Meyers B, Decker PA, Putnam JB Jr., McKenna RW, Landrenau RJ, Jones DR, Inculet RI, Malthaner RA. Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg. 2010 Apr; 139(4): 976-81. PMID:20172539


134. Grogan EL, Deppen S, Pecot CV, Putnam JB Jr., Nesbitt JC, Shyr Y, Rajanbabu R, Ory B, Lambright ES, Massion PP. Diagnostic characteristics of a serum biomarker in patients with positron emission tomography scans. Ann Thorac Surg. 2010 Jun; 89(6): 1724-8. PMID:20494018

135. Isbell, JM Deppen S, Putnam JB Jr., Nesbitt JC, Lambright ES, Dawes A, Massion PP, Speroff T, Jones DR, Grogan EL. Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Ann Thorac Surg, 2011 Jan; 91(1):227-33. PMID:21172518

136. St. Julien J, Putnam JB Jr., Nesbitt JC, Lambright ES, Petracek MR, Grogan EL. Successful treatment of atrioesophageal fistula via cervical esophageal ligation and decompression. Annals of Thoracic Surgery, June 2011, 91: e85-e86. PMID:21619954

137. Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, Jones DR, McKenna R, Landreneau R, Rusch VW, Putnam JB Jr. Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient with N0 or N1 (Less Than Hilar) Non-Small Cell Carcinoma: Results of the ACOSOG Z0030 Trial. J. Thorac Cardiovas. Surg., March 2011, 141: 662-670. PMID:21335122

138. Rahman SM, Gonzalez AL, Ming Li, Seeley EH, Zimmerman LJ, Zhang XJ, Manier ML, Olson SJ, Shah RN, Miller AN, Putnam JB Jr., et. al. Lung Cancer Diagnosis from Proteomic Analysis of Preinvasive Lesions. Cancer Res, April 15, 2011; 3009. PMID:21487035

139. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB Jr., Vaporciyan AA. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol 2011 Mar 10;29(8): 994-1000. PMID:21282546

140. Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, Jones DR, McKenna RJ, Landreneau RJ, Putnam JB Jr. Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial. Chest. 2011 May; 139(5): 1124-1129. PMID:20829340

141. Deppen S, Putnam JB Jr., Andrade G, Speroff T, Nesbitt JC, Lambright ES, Massion PP, Walker R, Grogan EL. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg., 2011 Aug; 92(2): 428-32. PMID:21592456

142. Fernando HC, Landreneau RJ, Mandrekar SJ, Hillman SL, Nichols FC, Meyers B, DiPetrillo TA, Heron D, Jones DR, Daly BD, Starnes SL, Hatter JE, Putnam JB Jr. The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial. J Thorac Cardiovasc Surg. 2011 Sep; 142(3):554-62. PMID:21724195

143. Grogan EL. Weinstein JJ. Deppen SA. Putnam JB Jr. Nesbitt JC. Lambright ES. Walker RC. Dittus RS. Massion PP. Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. 6(10):1720-5, 2011 Oct.

144. Rusch VW, Hawes D, Decker PA, Martin SE, Abati A, Landreneau RJ, Patterson GA, Inculet RI, Jones DR, Malthaner RA, Cohen RG, Ballman K, Putnam JB Jr., Cote RJ. Occult Metastases in Lymph Nodes Predict Survival in Resectable Non-Small Cell Lung Cancer. Journal of Clinical Oncology, 2011 Nov 10:29(32):4313-9. PMID:21990404

145. Fernando HC, Landreneau RJ, Mandrekar SJ, Hillman SL, Nichols FC, Meyers B, DiPetrillo TA, Heron DE, Jones DR, Daly BD, Starnes SL, Tan A, Putnam JB Jr. Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. J Thorac Cardiovasc Surg. 2011 Nov; 142(5): 1143-51. PMID:21872277

146. Pecot C, Li M, Zhang X, Rajanbabu R, Calitri C, Bungum A, Jett J, Putnam,. JB, Callaway-Lane C, Deppen S, Grogan E, Carbone D, Worrell J, Moons K, Shyr Y, Massion P. Added value of a serum proteomic

20

http://www.ncbi.nlm.nih.gov/pubmed?term=Thirty-%20and%20ninety-day%20outcomes%20after%20sublobar%20resection%20with%20and%20without%20brachytherapy%20for%20non-small%20cell%20lung%20cancer%3A%20results%20from%20a%20multicenter%20phase%20III%20study.


http://www.ncbi.nlm.nih.gov/pubmed?term=The%20impact%20of%20adjuvant%20brachytherapy%20with%20sublobar%20resection%20on%20pulmonary%20function%20and%20dyspnea%20in%20high-risk%20patients%20with%20operable%20disease%3A%20preliminary%20results%20from%20the%20American%20College%20of%20Surgeons%20Oncology%20Group%20Z4032%20trial




http://www.ncbi.nlm.nih.gov/pubmed?term=Lung%20Cancer%20Diagnosis%20from%20Proteomic%20Analysis%20of%20Preinvasive%20Lesions.%20Cancer%20Res%2C%20April%2015%2C%202011%3B%203009





http://www.ncbi.nlm.nih.gov/pubmed?term=Video-assisted%20thoracic%20surgery%20versus%20open%20lobectomy%20for%20lung%20cancer%3A%20a%20secondary%20analysis%20of%20data%20from%20the%20American%20College%20of%20Surgeons%20Oncology%20Group%20Z0030%20randomized%20clinical%20trial.%20J%20Thorac%20Cardiovasc%20Surg


Joe B. Putnam, Jr., M.D. Rev. December 2012signature in the diagnostic evaluation of lung nodules. Cancer Epidemiology, Biomarkers & Prevention. 21(5):786-92, 2012 May. PMID:22374995

147. Gaspar LE. McNamara EJ. Gay EG. Putnam JB. Crawford J. Herbst RS. Bonner JA. . Small-cell lung cancer: prognostic factors and changing treatment over 15 years. Clinical Lung Cancer. 13(2):115-22, 2012 Mar. PMID:22000695

148. St Julien JB, Pinkerman R, Aldrich MC, Chen H, Deppen SA, Callaway-Lane C, Massion P, Putnam JB, Lambright ES, Nesbitt JC, Grogan EL. Poor survival for veterans with pathologic stage I non-small-cell lung cancer. Am J Surg. 2012 Aug 17. PMID:22906246


149. Nesbitt JC, St. Julien J, Absi TS, Ahmad RM, Grogan EL, Balaguer JM, Lambright ES, Deppen S, Wu H, Putnam JB Jr. Tissue-based coronary simulation: Medical student deliberate practice can achieve equivalency to senior surgery residents. J Thor Cardiovasc Surg, submitted, October, 2012.

Invited Articles:

1. Putnam JB Jr., and Roth, JA. Prognostic indicators in patients with pulmonary metastases. N. Martini (ed.),Semin. Surg. Oncol., 6:291 - 296, 1990. PMID:2237089

2. Putnam JB Jr., Akiyama, H. Surgery for cancer of the esophagus. Publishers Williams and Wilkins; reviewed for Cancer Bulletin 43:283, 1991.

3. Putnam JB Jr, Sanders, R.J., and Haug, CE. Thoracic Outlet Syndrome, Lippincott, reviewed for Mil. Med., 157:A7, 1992.

4. Putnam, JB Jr., Richter, J.E. (ed.), Ambulatory Esophageal Ph Monitoring: Practical Approach and Clinical Applications, reviewed for Mil. Med., 158:A9, 1992.

5. Lanza, L.A., Natarajan, G., Roth, J.A., and Putnam, JB Jr., Long-term survival following pulmonary metastases from carcinoma of the breast. Clinical Digest Series Respir Diseases Digest, 2:16, 1993. PMID:1637212

6. Putnam, JB Jr., Surgery for stage N2 lung cancer. Semin. Thorac. Cardiovasc. Surg., 5:249 - 257, 1993. PMID:8353152

7. Putnam, JB Jr., Suell, D.M., Natarajan, G., Roth, J.A. Extended resection of pulmonary metastases: Is the risk justified? Ann Thorac Surg 55: 1440 - 6, 1993. PMID:8512393

8. Gorenstein, L.A., Putnam, JB Jr., Balch, C.A., and Roth, J.A. Improved survival following resection of pulmonary metastases from malignant melanoma. Sel. Read Gen. Surg., 1993.

9. Putnam, JB Jr., and Roth, J.A. Resection of sarcomatous pulmonary metastases. Surg Oncol Clin N Am., 2:673 - 691, 1993.

10. Putnam, JB Jr., Prakash, U.B.S. (ed.), Bronchoscopy, Reviewed for Cancer Bulletin, 1994.11. Roth, J.A., and Putnam, JB Jr., Surgery for cancer of the esophagus. Semin. Oncol. 21:453 - 461, 1994.

PMID:751896712. Putnam, JB Jr., and Roth, J.A. Surgical treatment for pulmonary metastases from sarcoma. Hematol Oncol Clin North

Am, 9:869 - 887, 1995. PMID:749024613. Swisher, S.G., Roth, J.A., and Putnam, JB Jr., Diagnosis and Management of Benign Esophageal Tumors. Cancer

Bull., 47:396 - 401, 1995.14. Walsh, G.L., Morice, R.C., Putnam, JB Jr., Nesbitt, J.C., McMurtrey, M.J., Reising, J., Willis, K.M., Morton, J.D.,

and Roth, J.A. Resection of lung cancer is justified in high - risk patients selected by exercise oxygen consumption. In: R.J. Ginsberg, A.S. Wechsler, and W.G. Williams (eds.), The Year Book of Thoracic and Cardiovascular Surgery, pp 5 - 7, Chicago, IL., Mosby - Year Book, Inc., 1996. PMID:7944692

15. Lanza, L.A., Natarajan, G., Roth, J.A., and Putnam, JB Jr., Long-term survival following pulmonary metastases from carcinoma of the breast. Sel. Read Gen. Surg., 1996.

16. Komaki, R., Putnam, JB Jr., Shin, D.M., and Cox, J.D. Thymic neoplasms. Curr. Opin. Oncol., 9:156 - 160, 1997. PMID:9161794

17. Roth, J.A., Nguyen, D., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., Ferson, D.Z., Hong, W.K., Komaki, R., Lee, J.J, Nesbitt, J.C., Pisters, K.M.W., Putnam, JB Jr., Shea, R., Shin, D.M., Walsh, G.L., Dolormente, M.M., Han, C - I., Martin, F.D., Yen, N., Stephens, L.C., McDonnell, T.J., Mukhopadhyay, T., and Cai, D. Retrovirus - mediated wild - type p53 gene transfer to tumors of patients with lung cancer. Medical Briefs in Cancer, 2:4 - 5, 1997. PMID: 8782455

18. Roth, J.A., Swisher, S.G., Merritt, J.A., Lawrence, D.D., Kemp, B.L., Cesar H.C., El - Naggar, A.K., Fossella, F.V., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.M., Nesbitt, J.C., Pisters, K., Putnam, JB Jr., Schrump, D.S., Shin,

21









http://www.ncbi.nlm.nih.gov/pubmed?term=Long-term%20survival%20following%20pulmonary%20metastases%20from%20carcinoma%20of%20the%20breast%2C%20Putnam



http://www.ncbi.nlm.nih.gov/pubmed/22000695/


Joe B. Putnam, Jr., M.D. Rev. December 2012D.M., and Walsh, G.L. Gene therapy for non-small cell lung cancer: A preliminary report of a phase I trial of adenoviral p53 gene replacement. Semin. Oncol. 25:33 - 37, 1998. PMID: 9704675

19. Putnam, JB Jr., Complications of multimodality therapy. Chest Surg Clin N Am, 8: 663 - 680, 1998. PMID:9742342

20. Putnam, JB Jr. , Soft part sarcomas – metastases. Chest Surg Clin N Amer., 8:97-118, 1998. PMID:951517521. Komaki, R., Putnam, JB Jr., Walsh, G., Lee, J.S., and Cox, J.D. The management of superior sulcus tumors. Sem.

Surg. Oncol., 18(2):152 - 164, 2000. PMID:1065791722. Putnam, JB Jr., Lung cancer. Semin. Surg. Oncol., 18:89 - 90, 2000. PMID:1065790923. Komaki, R., Cox, J.D., Putnam, JB Jr., Walsh, G., Vaporciyan, A., Liao, Z., Stevens, C., Fossella, F.V., Lee, J.S.,

Hong, W.K., and Roth, J.A. The management of superior sulcus tumors, J Japanese Soc Ther Radiol Oncol, 13:131 - 138, 2001.

Invited Articles (cont.):

24. Putnam, JB Jr., The anatomic basis for lung cancer staging: the end of the beginning? Ann Thorac. Surg., 71:1757 - 1758, 2001. PMID:11426743

25. Putnam, JB Jr., New and evolving treatment methods for pulmonary metastases. Semin. Thorac. Cardiovasc. Surg., 14:49 - 56, 2002. PMID:11977017

26. Putnam, Jr., J. B., Malignant pleural effusions. Surgical Clinics of North America. 82:867 - 883, 2002. PMID:12472134

27. Ajani, J. A., Faust, J., Yao, J., Komaki, R., Stevens, C., Swisher, S., Putnam, Jr., J. B., Vaporciyan, A., Smythe, R., Walsh, G., Rice, D., and Roth, J. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Oncology (Williston Park). 17(9: Suppl 8), 2003. PMID:14569843

28. Eberhardt WE, Albain KS, Pass H, Putnam, JB Jr., Gregor A, Asamura H, Mornex F, Senan S, Belderbos J, Westeel V, Thomas M, Van Schil P, Vansteenkiste J, Manegold C, Mirimanoff RO, Stuschke M, Pignon J, Rocmans P, Shepherd FA. Induction treatment before surgery for non - small cell lung cancer. Lung Cancer 42, Suppl. 1:S9 - S14, 2003. PMID:14708516

29. Putnam, JB Jr., Royston D, Chambers AF, Dunbar S, Lemmer JH, Norman P, Travis E, Vaporciyan AA, Yang S, Zacharski LR. Evaluating the role of serine protease inhibition in the management of tumor micrometastases. Oncology (Williston Park) 17 (10 Suppl 10): Suppl - 30. PMID:14606367

30. Ajani JA, Faust J, Yao J, Komaki R, Stevens C, Swisher S, Putnam, JB Jr., Vaporciyan A, Smythe R, Walsh G, Rice D, Roth J. Irinotecan/cisplatin followed by 5 - FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Oncology (Williston Park). 2003 Sep; 17(9 Suppl 8):20 - 2. PMID:14569843

31. Putnam, JB Jr. Quality Improvement in Thoracic Surgery. Japanese Journal of Lung Cancer, Vol. 44, October 2004.

32. Putnam, JB Jr. Is Resection Necessary for Esophageal Carcinoma? Semin Oncol, 32(6 Suppl 9), S21 - 4, 2005. PMID:16399425

33. Oh Y, Mohiuddin I, Sun Y, Putnam JB, Jr., Hong WK, Arap W, Pasqualini R. Phenotypic diversity of the lung vasculature in experimental models of metastases. . Chest 2005 Dec; 128(6: Suppl):Suppl - 600S. PMID:16373855

34. Putnam, JB Jr., Invited commentary: Ann Thorac Surg 83: 424, 2007. PMID:1725796435. Antevil, JL, Putnam, JB Jr., Talc Pleurodesis for Malignant Effusions is Preferred over the PleurX Catheter (Pro

Position). Annals of Surgical Oncology; 14: 2698 - 2699, 2007. PMID:1765754436. Putnam JB Jr. Resection of pulmonary metastases: a mechanical solution for a biological problem. Oncology

(Williston Park). 25(12):1206-7, 2011 Nov 15. PMID:22229213

Editorials and Other Articles

1. Putnam, JB Jr., Palliation of central airway stenoses with the Dumon silicone stent. Editorial on Bolliger CT,Probst R, Tschopp K, Soler M, Perruchoud AP: Silicone stents in the management of inoperable tracheobronchial stenoses: Indications, limitations. Chest, 104:1651 - 1652, 1993. PMID:7504607

2. Benjamin, R.S., and Putnam, JB Jr., Another half step. Ann Thor Surg, 1995.3. Putnam, JB Jr., The anatomic basis for lung cancer staging: the end of the beginning?, Ann Thor Surg, 71:1757 -

58, 2001. PMID:114267434. Gaissert HA, Casale AS, Creswell LL, Ferguson TB Jr., Fullerton DA, Kernstine KH, McMullan DM, Ring WS,

Putnam, JB Jr., (Society of Thoracic Surgeons Workforce on Clinical Trials). Mentoring clinical trials in thoracic and cardiovascular surgery: a new role for the Society of Thoracic Surgeons. Ann Thor Surg. 77: 1874 - 5, 2004. PMID:15111218

22












http://www.ncbi.nlm.nih.gov/pubmed?term=Ajani%2C%20J.%20A.%2C%20Faust%2C%20J.%2C%20Yao%2C%20J.%2C%20Komaki%2C%20R.%2C%20Stevens%2C%20C.%2C%20Swisher%2C%20S.%2C%20Putnam%2C%20Jr.%2C%20J.%20B.%2C%20Vaporciyan%2C%20A.%2C%20Smythe%2C%20R.%2C%20Walsh%2C%20G.%2C%20Rice%2C%20D.%2C%20and%20Roth%2C%20J.%20Irinotecan%2Fcisplatin%20followed%20by%205-FU%2Fpaclitaxel%2Fradiotherapy%20and%20surgery%20in%20esophageal%20cancer.%20Oncology%20(Williston%20Park).%2017(9%3A%20Suppl%208)%2C%202003




http://www.ncbi.nlm.nih.gov/pubmed?term=Putnam%2C%20JB%20Jr.%2C%20Lung%20cancer.%20Semin.%20Surg.%20Oncol.%2C%2018%3A89%20-%2090%2C%202000





Joe B. Putnam, Jr., M.D. Rev. December 20125. You YN, Hunt KK, Posner MC, Putnam, JB Jr., Nelson H, Ota DM, Pisters PWT. Operative Trials: The

Opportunity Beckons-An Update of the American College of Surgeons Oncology Group. Surgery 2006 139:455-9. PMID:16627052

6. Putnam, JB Jr., Results of chest wall resection and reconstruction with and without rigid prosthesis (Invited Commentary). Ann. Thorac Surg, 2006; 81: 285. PMID:16368381

7. Putnam, JB Jr. Preoperative Serum Carcinoembryonic Antigen Level is a Prognostic Factor in Females with Early Non - small Cell Lung Cancer (Invited Commentary), Ann of Thorac Surg, 2007; 83:424. PMID:17257964

8. Putnam, JB Jr. “Resection of Pulmonary Metastases: a Mechanical Solution for a Biological Problem” (Invited Commentary on article by Martin and Kon on surgery for pulmonary metastases of sarcoma), Oncology (Williston Park), 2011 Nov 15;25(12):1206-7. PMID:22229213

Abstracts

1. Ferson, D.Z., Nesbitt, J.C., Walsh, G.L., Putnam, JB Jr., Schrump, D.S., Nesbitt, K.K., Jones, R.L., Johansen, M.J., Jones, R.L., and Roth, J.A. The laryngeal mask airway: A new standard for airway evaluation in thoracic surgery. Society of Thoracic Surgeons Annual Meeting, San Diego, CA, Proc. Soc. Thorac. Surg., 1997. PMID:9066399

2. Gokaslan, Z.L., McCutcheon, I.E., Walsh, G.L., Putnam, JB Jr., and Nesbitt, J.C. Transthoracic vertebrectomy in cancer patients. Association’s Annual Meeting of the American Association of Neurological Surgeons, Denver, Colorado, 1997. PMID:9761054

3. Benjamin, R.S., Putnam, JB Jr., Tran, H.T., Hager, H.K., and Madden, T. High levels of doxorubicin in human lung and pulmonary metastases following single-pass isolated-single-lung perfusion. American Association Cancer Research Annual Meeting, San Diego, CA, Pro. Am. Assoc. Cancer Res., 1997.

4. Swisher, S.G., Roth, J.A., Lawrence, D., Kemp, B., Carrasco, C., Fossella, F., Glisson, B., Hong, W.K., Khuri, F., Kurie, J., Nesbitt, J.C., Pisters, K., Putnam, JB Jr., Schrump, D., Shin, D., and Walsh, G.L. Adenoviral mediated p53 gene transfer in patients with advanced non- small cell lung cancer (NSCLC). Proc. Am. Soc. Clin Oncol., Denver, Colorado, 1997.

5. Shin, D.M., Komaki, R., Putnam, JB Jr., Walsh, G.L., Nesbitt, J.C., Ro, Y., Schea, D., Schrump, D.S., Cox, J.D., Roth, J.A., and Hong, W.K. Induction chemotherapy (IC) followed by surgical resection (SR), stages of unresectable invasive thymoma. Proc. Am. Soc. Clin. Oncol., Denver, Colorado, 1997.

6. Putnam, JB Jr., Madden, T., Tran, H.T, Benjamin, R.S. Isolated single lung perfusion (ISLP) with adriamycin for unresectable sarcomatous metastases. Proc ASCO 16 [#1799], 500a. 1997.

7. Shin, D.M., Komaki, R., Putnam, JB Jr., Walsh, G.L., Nesbitt, J.C., Ro, Y., Schea, R.A., Pisters, K.M.W., Schrump, D., Gregurich, M.A., Cox, J.D., Roth, J.A., and Hong, W.K. Multidisciplinary approach of therapy for advanced stages of unresectable invasive thymoma. 1st International Meeting on Advances in the Knowledge of Cancer Management, UICC, Vienna, Austria, 1997.

8. Roth, J.A., Swisher, S.G., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., El - Naggar, A.K., Fossella, F.V., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.C., Nesbitt, J.C., Pisters, K., Putnam, JB Jr., Schrump, D.S., Shin, D.M., and Walsh, G.L. Department of Thoracic and Cardiovascular Surgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA, Gene Replacement for Lung Cancer. 8th World Conference on Lung Cancer, Journal of the International Association for the Study of Lung Cancer, 18:76, Dublin, Ireland, 1997.

9. Roth, J.A., Swisher, S.G., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., El - Naggar, A.K., Fossella, F.V,, Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.C., Nesbitt, J.C., Pisters, K., Putnam, JB Jr., Schrump, D.S., Shin, D.M., and Walsh, G.L. Department of Thoracic and Cardiovascular Surgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA, Gene Therapy Strategies for Lung Cancer. 8th World Conference on Lung Cancer, Journal of the International Association for the Study of Lung Cancer, 18:141, Dublin, Ireland, 1997.

10. Shin, D.M., Komaki, R., Putnam, JB Jr., Walsh, G.L., Nesbitt, J.C., Ro, J.Y., Schea, R.A., Pisters, K.W.M., Schrump, D.S., Gregurich, M.A., Cox, J.D., Roth, J.A., and Hong, W.K. Induction chemotherapy (C) followed by surgical resection (SR), radiotherapy (RT), and consolidative chemotherapy (CC) may cure the advanced stages of unresectable thymoma. American Society of Clinical Oncology Annual Meeting, Denver, CO, Proc. Am. Soc. Clin. Oncol., 1997.

11. Nesbitt, J.C., Ferson, D.Z., Walsh, G.L., Schrump, D.S., Swisher, S.G., Nesbitt, K.K., and Putnam, JB Jr., The laryngeal mask airway and laser bronchoscopy for tumors of the tracheobronchial tree. Southern Thoracic Surgical Association Annual Meeting, Chicago, IL, 1997.

23







Joe B. Putnam, Jr., M.D. Rev. December 201212. Nesbitt, J.C., Whitehead, W.E., Darwish, A.A., Walsh, G.L., Schrump, D.S., Swisher, S.G., Willis, K.D., Roth, J.A.,

and Putnam, JB. Survival and operative risk following pneumonectomy. American College of Chest Physicians Chest ’97 Meeting, New Orleans, LA, 1997.

12. Nesbitt, J.C., Ferson, D.Z., Walsh, G.L., Schrump, D.S., Swisher, S.G., Nesbitt, K.K., and Putnam, JB Jr., The laryngeal mask airway: A valuable adjunct for laser bronchoscopy of obstructive tumors. American College of Chest Physicians Chest ’97 Meeting, New Orleans, LA, 1997.

13. Putnam, JB Jr., Ponn, R., Olak, J., Pollak, J., Lee, R.B., Light, R., Alonso, A., Payne, D.K., Graeber, G., Kovitz, K., Brown, B., and Rodriguez, M. Pleural Catheter Study Group: A phase III trial of treatment for malignant pleural effusions: Pleurx® pleural catheter (PC) versus chest tube + doxycycline sclerosis (CT-S). American College of Chest Physicians Chest ’97 Meeting, New Orleans, LA, 1997.

14. Putnam, JB Jr., Madden, T., Tran, H.T., and Benjamin, R.S. Isolated single lung perfusion (ISLPP) with Adriamycin for unresectable sarcomatous metastases. Connective Tissue Oncology Society, Milan, Italy, 1997.

15. Swisher, S.G., Hu, M., Holmes, E.C., Hunt, K., Ajani, J., McFadden, D., Nelson, S., Nesbitt, J., Putnam, JB Jr., Vaporciyan, A.A., Walsh, G.L., Sinner, M., and Roth, J.A. The University of Texas M. D. Anderson Cancer Center, Houston Texas and University of California at Los Angeles, Los Angeles, California. Impact of Number of Involved Lymph Nodes on Long-Term Survival in Esophageal Cancer. Society of Surgical Oncology 51st Annual Cancer Symposium, San Diego, California, 1998.

Abstracts (cont.)

16. Ueno, N.T., Hung, M.C., Zhang, S., Xia, W., Willey, J.S., Warner, D.L., Payne, J.Y., Nandagiri, R., Aldridge, R., De Jager, RL., Tucker, S., Putnam, JB Jr., Sneige, N., Katz, R.L., Spohn, W.H., Bast, R.C., Holmes, F.A., Ibrahim, N.K., Theriault, R.L., Rahman, Z.U., Valero, V., Kudelka, A.P., Kavanagh, J.J., Freedman, R.S., Wolf, J.K., Gershenson, D.M., Bevers, M.W., Huang, L., Lopez - Berestein, G., and Hortobagyi, G.N. Phase I E1A gene therapy in patients with advanced breast and ovarian cancers. American Association for Cancer Research, New Orleans, LA, 1998.

17. Shin, D.M., Walsh, G.L., Putnam, JB Jr., Komaki, R., Cox, J.D., Roth, J.A., and Hong, W.K. Recent Advances in the Management of Malignant Thymoma. 41st Annual Clinical Conference, “New Frontiers in Research and Treatment of Aerodigestive Tract Cancers”, Houston, Texas, 1998.

18. Swisher, S.G., Roth, J.A., Neumanitis, J., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., Connors, D.G., El - Naggar, A.K., Fossela, F.V., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.M., Lee, J.J., Lee, J.S., Merritt, J.A., Nesbitt, J.C., Nguyen, D., Pisters, K.M.W., Putnam, JB Jr., Schrump, D.S., Shin, D.M., Perez - Soler, R., and Walsh, G.L. Adenoviral mediated p53 gene transfer in patients with advanced non-small cell lung cancer (NSCLC). American Society of Clinical Oncology, Los Angeles, CA, 1998.

19. Nesbitt, J.C., Ajani, J.A., Komaki, R., Walsh, G.L., Putnam, JB Jr., Swisher, S.G., Pisters, P., Lynch, P., Raijman, I., Pazdur, R., Delclos, M., and Martin, F. Preoperative taxol - based chemotherapy (CT) followed by chemoradiation therapy (CTRT) in patients (PTS) with potentially resectable esophageal carcinoma (EC). American Society of Clinical Oncology, Los Angeles, CA, 1998.

20. Putnam, JB Jr., Roth, J.A., Walsh, G.L., Swisher, S.G., Merriman, K.W., and DeFord, L.L. The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. Early Cost Comparison between Tube Thoracostomy vs. Chronic Indwelling Pleural Catheter (Pleurx) for Treatment of Malignant Pleural Effusion. Southern Thoracic Surgical Association, Orlando, Florida, 1998.

21. Gandhi, S., Gokaslan, Z., Komaki, R., Putnam, JB Jr., Roth, J.A., Smythe, W.R., Walsh, G.L., Willis, K.M., Vaporciyan, A.A., and Swisher, S.G. An Aggressive Multidisciplinary Surgical Approach to Superior Sulcus Tumors with Vertebral Invasion can lead to Long-Term Survival. The Society of Thoracic Surgeons, San Antonio, Texas, 1998.

22. Swisher, S.G., Nemunaitis, J., Roth, J.A., Lawrence, D., Kemp, B., El - Naggar, A., Hong, W.K., Mack, M., Weill, D., Merritt, J., Putnam, JB Jr., and Walsh, G.L. Outcome of Intralesional Adenoviral p53 Gene replacement with or without Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer. Proceedings of the American Association of Thoracic Surgery, 1999.

23. Smythe, W.R., Consorti, E., Walsh, G.L., Putnam, JB Jr., Swisher, S.G., Vaporciyan, A.A., and Roth, J.A. Surgical Therapy for Metastatic Thyroid Carcinoma to the Mediastinum and Lung. Society of Thoracic Surgeons, Fort Lauderdale, Florida, 2000.

24. Walsh, G.W., Davis, B.M., Swisher, S.G., Vaporciyan, A.A., Smythe, W.R., Roth, J.A., and Putnam, JB Jr., A Single - Institution, Multidisciplinary Approach to Primary Sarcomas Involving the Chest Wall Requiring Full Thickness Resections, American Association for Thoracic Surgery, Toronto, Ontario, Canada, 2000.

25. Putnam, JB Jr., Benjamin, R.S., Rha, S.J., Tran, H.T., Walsh, G.L., Swisher, S.G., et al. Early results of isolated single lung perfusion for treatment of unresectable sarcomatous metastases. American Association for Thoracic Surgery 80th Annual Meeting (Toronto, Canada), April 30–May 3, 2000.

24

Joe B. Putnam, Jr., M.D. Rev. December 201226. Putnam, JB Jr., Thomsen, S.L., and Siegenthaler, M. Therapeutic Implications of Heat-Induced Lung Injury.

SPIE’s BiOS 2000 The International Symposium on Biomedical Optics, San Jose, California, 2000.27. Siegenthaler, M., Pisters, K.M., Merriman, K.W., Swisher, S.G., Roth, J.A., Walsh, G.L., Vaporciyan, A.A., Smythe,

W.R., and Putnam, JB Jr.. Preoperative Chemotherapy for Lung Cancer Does Not Increase Surgical Morbidity. 36th

Annual Meeting of The Society of Thoracic Surgeons, 2000. PMID:1130814428. Lewin, J.S., Hebert, T.M., DuBrow, R.A., and Putnam, JB Jr., Experience with the Chin Tuck Maneuver in Post -

Esophagectomy Aspirators. Dysphagia Research Society 9th Annual Scientific Meeting, Savannah, Georgia, 2000. 29. Walsh, G.L., Bryan, M.D., Swisher, S.G., Vaporciyan, A.A., Smythe, W.R., Willis - Merriman, K., Roth, J.A., and

Putnam, JB Jr., A Single-Institutional, Multidisciplinary Approach to Primary Sarcomas Involving the Chest Wall requiring Full Thickness Resections. AATS 80th Annual Meeting, Toronto, Ontario, Canada, 2000.

30. Vaporciyan, A.A., Merriman, K.W., Ece, F., Roth, J.A., Smythe, W.R., Swisher, S.G., Walsh, G.L., and Putnam, JB Jr., Impact of Timing of Smoking Cessation on Pulmonary Morbidity after Pneumonectomy, Southern Thoracic Surgical Association, Marco Island, Florida, 2000.

31. Schnirer, I., Komaki, R., Yao, J., Swisher, S.G., Putnam, JB Jr., Pisters, P., Roth, J.A., Yan, M., Janjan, N., Mansfield, P., Feig, B., and Ajani, J. A Study of Concurrent 5FU/Paclitaxel and Radiotherapy in Patients with Carcinoma of the Upper Gastrointestinal Tract. Immunobiol and Biologic Ther., 2000.

25



Abstracts (cont.)

32. Swisher, S.G., Roth, J.A., Komaki, R., Hicks, M., Dreiling, L., Yver, A., Ahrar, K., Morello, F., Shelton, T., Dolormente, M., Francisco, R., Vaporciyan, A.A., Smythe, W.R., Putnam, JB Jr., Steven, C., Kelly, J., Liao, Z., Kemp, B., Hong, W.K., Munden, R., Ro, J., Morice, R., Huaringa, A., Mosheim, M., and Walsh, G.L. A Phase II Trial of Adenoviral Mediated P53 Gene Transfer (RPR.INGN 201) in Conjunction with Radiation therapy in Patients with Localized Non - Small Cell Lung Cancer (NSCLC), American Society of Clinical Oncology 19, 461a - 461a, 2000.

33. Komaki, R., Roth, J.A., Putnam, JB Jr., Swisher, S., Vaporciyan, A., Lee, J.S., Fossella, F., Chasen, M., and Cox, J.D. Multidisciplinary approach for 143 patients with superior sulcus tumors treated at University of Texas M.D. Anderson Cancer Center. J ASTRO 12:110, 2000.

34. Mohiuddin, I.*, Sharma, C., Burnett, M., Putnam, JB Jr., Vaporciyan, A. Characterization of acute lung injury after isolated lung perfusion with doxorubicin, Am. College of Chest Phys., 118:1535, 2000.

35. Swisher, S.G., Ajani, J.A., Komaki, R.R., Walsh, G.L., Nesbitt, J.C., Martin, F.D., Lahotie, S., Smythe, W.R., Vaporciyan, A.A., Putnam, JB Jr., and Roth, J.A. Improved long-term survival in esophageal cancer following the novel strategy of induction chemotherapy prior to concurrent chemoradiation and surgery, Western Thoracic Surgical Association Meeting, San Diego, CA, 2001.

36. Ajani, J., Komaki, r., Walsh, G.L., Putnam, JB Jr., Swisher, S.G., Lahoti, S., Ho, L., Faust, J., Roe, J., Smythe, W.R., Vaporciyan, A. a., Pisters, P., Kelly, J., Stevens, C., and Roth, J.A. CPT-11 plus cisplatin as induction chemotherapy followed by chemoradiotherapy in resectable carcinoma of the esophagus and GE junction (EC - GEJC). Proc. Am. Soc. Clin. Oncol., 20 430a, 2001.

37. Xiong, Q., Yao, J.C., Phan, A., Giacco, G., Hess, K., Roth, J. A., Putnam, JB Jr., Walsh, G.L., Swisher, S.G., Mansfield, P.F., Pisters, P.W., Feig, B.W., and Ajani, J.A. Frequency of esophagogastric junction involvement among upper gastrointestinal cancers. Proc. Am. Soc. Clin. Oncol., 20, 430a, 2001.

38. Swisher, S.G., Roth, J.A., Komaki, R., Hicks, M., Ro, J., Hong, W.K., Ahrar, K., Atkinson, N., Correa, A. M., Dolormente, M., Dreiling, L., Fossella, F., Francisco, R., Glisson, B., Grammer, S., Herbst, R., Huaringa, A., Gu, J., Kelly, J., Kemp, B., Khuri, F.R., Kurie, J. M., Lee, J. J., Lee, J. S., Liao, Z., McDonnell, T. J., Merritt, J. A., Morice, R., Morello, F., Mosheim, M., Munden, R., Papadimitrakopoulou, V., Pisters, K. M. W., Putnam, JB Jr., Sarabia, A. J., Shelton, T., Stevens, C., Shin, D.M., Smythe, W. R., Vaporciyan, A., Walsh, G. L., Yin, M., and Yver, A. Induction of p53 regulated genes and tumor regression in lung cancer following intratumoral delivery of adenoviral p53 (RPR/INGN 201) and radiation therapy. Proc. Am. Soc. Clin. Oncol., 20, 257a, 2001.

39. Reinmuth, N., Ahmad. S. A., Curley, S. A., Vauthey, J. N., Putnam, JB Jr., and Ellis, L. M. Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Proc. Am. Soc. Clin. Oncol., 20, 105b, 2001.Pisters, K., Ginsberg, R., Giroux, D., Kris, M., Putnam, JB Jr., Roberts, J. R., Johnson, D. H., Crowley, J., and Bunn, P. Phase II bimodality lung oncology team (BLOT) trial of induction paclitaxel/carboplatin (PC) in early stage non - small cell lung cancer (NSCLC): effect of number of induction cycles, sites of relapse and survival. Proc. Am. Soc. Clin. Oncol., 20, 323a, 2001.

40. Kim, E.S., Putnam, JB Jr., Komaki, R., Walsh, G.L., Ro, J. Y., Shin, H.J., Lee, J.J., Swisher, S. G., Fossela, F. V., Khuri, F. R., Hong, W. K., and Shin, D. M. A phase II study of a multidisciplinary approach with induction chemotherapy (IC), followed by surgical resection (SR), radiation therapy (RT) and consolidation chemotherapy (CC) for unresectable malignant thymomas: final report. Proc. Am. Soc. Clin. Oncol., 20, 310a, 2001.

41. Swisher, S., Wynn, P., Mosheim, M., Putnam, JB Jr., Komaki, R., Ajani, J., Smythe, W.R., Vaporciyan, A., Roth, J., and Walsh, G. Is surgical salvage indicated for recurrent esophageal tumors following definitive chemoradiation? Proc. Am. Soc. Clin. Oncol., 146:46, 2001.

42. Yang, S. C., Whyte, R. I., Askin, F., Thomsen, S. L., Tamboli, P, Berry, G., Roig, C., and Putnam JB, Jr., Radiofrequency Ablation of Primary and Metastatic Lung Tumors: Analysis of an Ablate and Resection Study. American Association for Thoracic Surgery 82nd Annual Meeting, 210. 2002.

43. Putnam, JB Jr., Roberson, S. L., Lewin, J. S., Correa, A. M., Swisher, S. G., Walsh, G. L., Rice, D. C., Vaporciyan, A. A., Roth, J. A., and Smythe, W. R. Risk Analysis For Pneumonia Following Esophagectomy. The Society of Thoracic Surgeons 39th Annual Meeting 39, 258 - 259. 2003.

44. Rice, D. C., Kim, H. W., Smythe, W. R., Swisher, S. G., Vaporciyan, A. A., Putnam, JB Jr., Walsh, G. L., Lippman, S. M., Roth, J. A., Sabichi, A., and Lee, J. J. The Risk Of Second Primary Lung Cancer After Resection Of Stage I Non-Small Cell Lung Cancer. The Society of Thoracic Surgeons 39th Annual Meeting 39, 108. 2003.

45. Meyers, B.F., Downey, R.J., Kenan, R.J., Siegel, B.A., Cerfolio, R.J., Landreneau, R.J., Putnam, JB Jr., et al. The utility of positron emission tomography in staging of patients with potentially operable carcinoma of the thoracic esophagus. American Association for Thoracic Surgery Annual Meeting, Philadelphia, PA, 2006. PMID:17320575

26



Abstracts (cont.)

46. Toloza, E.M., Meyers, B.F., Mackie - McCall, L., Reed, C.E., Putnam, JB Jr. Prevalence of mediastinal metastases and sensitivity of mediastinoscopy in potentially operable non-small cell lung cancer screened by computerized tomography and positron emission tomography. American Association for Thoracic Surgery Annual Meeting, Abstract # 19; Philadelphia, PA, 2006.

47. Allen, M.S., Darling, G.E., Decker, P.A., Putnam, JB Jr., Malthaner, R.A., Inculet, R.I., Jones, D.R., McKenna, R.J., Landreneau, R.J. Number of lymph nodes harvested from a mediastinal lymphadenectomy; results of the randomized, prospective ACOSOG Z0030 trial. ASCO Annual Meeting, Chicago, IL, July 2007.

48. Deppen, SA, Andrade GM, Lambright ES, Nesbitt JC, Massion PP, Putnam JB Jr, Grogan EL. FDG-PET does not accurately diagnose early stage lung cancer in an area of endemic histoplasmosis and other granulomatous disease. Cancer Epidemiology, Biostatistics and Bioinformatics Retreat – Vanderbilt Ingram Cancer Center, Nashville, TN; December 4, 2009.

49. Fibla JJ, Putnam JB Jr, Ota D. Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030). American Society of Clinical Oncology, 2010.

50. Hillman SL, Landreneau RJ; Meyers B, Nichols FC, Dipetrillo T, Jones D, Benedict D, Putnam JB Jr. The Impact of Adjuvant Brachytherapy with Sublobar Resection on Pulmonary Function and Dyspnea in High-risk Operable Patients; Preliminary results from the ACOSOG Z4032 Trial. Journal of Thoracic and Cardiovascular Surgery, 2011.

51. Kent M, Landreneau RJ, Mandrekar SJ, Hillman SL, Nichols FC, Jones DR, Starnes SL, Tan A, Putnam JB Jr., Meyers B, Daly BDT, Fernando HC. Segmentectomy is superior to wedge resection for non-small cell lung cancer in high-risk operable patients. Southern Thoracic Surgical Association, submitted, 2012.

52. Fernando H, Landreneau R, Mandrekar S, Hillman S, Nichols F, DiPetrillo T, Heron D, Meyers B, Jones D, Starnes S, Putnam JB Jr. Thirty- and Ninety-Day Outcomes After Sublobar Resection for Non-Small Cell Lung Cancer

(NSCLC); Results from a Multicenter Phase III Study. AATS Annual Meeting, May 2011.53. Cuadrado DG, Nesbitt JC, Putnam JB Jr. Application of Live-Tissue Cardiac and Thoracic Simulation for Junior

General Surgical Residents. Submitted, American College of Surgeons Clinical Congress, October, 2011.54. Deppen S, Putnam JB Jr., Speroff T, Nesbitt J, Lambright E, Aldrich M, and Grogan E. Multiple Imputation in a

Clinical Prediction Model for Lung Cancer. North American Congress of Epidemiology, June, 2011.55. Grogan EL, Weinstein JJ, Deppen SA, Putnam JB Jr., Nesbitt JC, Lambright ES, Walker RC, Dittus RS, Massion

PP. Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease. J Thorac Oncol, 2011 Oct; 6(10): 1720-5. PMID:21760552

56. Grogan EL, Deppen S, Ballman K, Andrade GM, Verdail FC, Aldrich MC, Chen H, Decker PA, Harpole D, Cerfolio R, Keenan R, Jones DR, D’Amico TA, Shrager JB, Meyers BF, Putnam JB Jr. Accuracy of FDG-PET to diagnose lung cancer in the ACOSOG Z4031 trial. American Society of Clinical Oncology, accepted, 2012.

57. Reed CE, Decker PA, Schefter TE, Meyers BF, Ferguson MK, Oeltjen AR, Putnam, JB Jr., Cassivi SD, Lockhart AC. A Phase II study of neoadjuvant therapy with cisplatin, docetaxel, panitumumab plus radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051). American Society of Clinical Oncology, submitted, 2012.

58. Pezzi C, Gay G, Kulkarni N, Putnam JB Jr. Survival in 55,122 patients with resected Stage I Non-Small Cell Lung Cancer. Society of Surgical Oncology, submitted, 2012.

59. Deppen SA, Aldrich MC, Walker R, Necessary CA, Chen C, Wu H, Blume J, Massion P, Speroff T, Dittus R, Putnam JB Jr, Grogan EL. “A new model improves lung cancer prediction in the preoperative evaluation of patients with suspicious lung lesions.” American Association for Clinic Research, submitted, November 2012.

Book Chapters

1. Putnam, JB Jr., and Roth, J.A. Resection of pulmonary metastases. In: J.E. Niederhuber (ed.), Current Therapy in Oncology, pp. 197 - 201, Philadelphia, B.C. Decker, Inc., 1992.

2. Putnam, JB Jr., Ryan, M.B., Walsh, G.L., and Roth, J.A. Malignant disease of the lung. In: E.M. Copeland, III, and B.A. Levine (eds.), Current Practices of Surgery, pp. 1 - 44, New York, Churchill Livingstone, Inc., 1993.

3. Putnam, JB Jr., and Roth, J.A. Resection of sarcomatous pulmonary metastases. soft tissue Sarcomas of the limbs, In: W. Lawrence, Jr. (ed.), Surgical Oncology Clinics of North America, pp. 673 - 691, Philadelphia, W.B. Saunders Co., 1993.

4. Putnam, JB Jr., and Roth, J.A. Neoplastic Diseases of the Esophagus. In: R.H. Bell, L.F. Rikkers, and M.W. Mulholland (eds.), Digestive Tract Surgery: A Text and Atlas, pp. 43 - 75, Philadelphia: J.B., Lippincott, 1993.

5. Roth, J.A., and Putnam, JB Jr., Cancer of the esophagus. In: V.T. DeVita, Jr., S. Hellman, and S.A. Rosenberg (eds.), Cancer: Principles & Practice of Oncology, pp. 776 - 817, Philadelphia: J.B., Lippincott Co., 1993.

27



Book Chapters (cont.)

6. Putnam, JB Jr., and Roth, J.A. Surgical resection of pulmonary metastases. In: R.J. McKenna, and G.P. Murphy (eds.), Cancer Surgery, Philadelphia, pp. 337 - 350, J.B., Lippincott Co., 1994.

7. Putnam, JB Jr., Esophagectomy for carcinoma of the esophagus. In: M. Roh (ed.), Atlas of Advanced Oncologic Surgery, pp. 704 - 711, New York, Gower Med Publishing, 1994.

8. Putnam, JB Jr., and Roth, J.A. Secondary tumors in the lung. In: T. W. Shields (ed.), General Thoracic Surgery, pp. 1334 - 1352, Philadelphia, Lea and Feibiger Publishers, 1994.

9. Roth, J.A., and Putnam, JB Jr., New insights into selecting patients likely to benefit from resection of pulmonary metastases. In: G. Motta and L.P. Grafica (ed.), Lung Cancer Frontiers in Science and Treatment, pp. 473 - 482, Genoa, Italy, 1994.

10. Roth, J.A., and Putnam, JB Jr. Surgery for carcinoma of the esophagus. In: J.R. Ruckdeschel, and T. Weisenberger (eds.), Thoracic Oncology, pp. 397 - 432, Philadelphia, W.B. Saunders, 1995.

11. Putnam, JB Jr., and Roth, J.A. Neoplasms of the esophagus. In: R.H. Bell, L.F. Rikkers, and M.W. Mulholland (eds.), Digestive Tract Surgery: A Text & Atlas, pp. 43 - 76, Philadelphia, J. B. Lippincott Company, 1995.

12. Nesbitt, J.C., Putnam, JB Jr., Walsh, G.L., Ryan, M.B., and Roth, J.A. Malignant diseases of the lung. In: B.A. Levine, E.M. Copeland III, R.F. Howard, H.J. Sugerman, and A.L. Warshaw (eds.), Current Practice of Surgery, pp. 1 - 54, New York, Churchill Livingstone Inc., 1995.

13. Lanza, L.A., and Putnam, JB Jr., Resection of pulmonary metastases. In: J.A. Roth, J.R. Ruckdeschel, and T.H. Weisenberger (eds.), Thoracic Oncology 2nd Edition, pp. 569 - 589, Philadelphia, W.B. Saunders, 1996.

14. Putnam, JB Jr., Exploratory Thoracoscopy. In: B. MacFadyen, and J. Ponsky (eds.), Operative Laparoscopy and Thoracoscopy, pp. 829 - 848, New York, Raven Press, 1996.

15. Roth, J.A., Putnam, JB Jr., Rich, T., and Forestiere, A. Cancer of the esophagus. In: V.T. DeVita, S. Hellman, and S.A. Rosenberg (eds.), CANCER: Principles and Practices of Oncology, pp. 980 - 1010, Philadelphia, J.B., Lippincott - Raven, 1996.

16. Roth, J.A., and Putnam, JB Jr., Pulmonary resection for metastatic disease. In: H. Silberman, and A.W. Silberman (eds.), Difficult Problems in Surgical Oncology, New York, Chapman and Hill, 1996.

17. Roth, J.A., Beech, D.J., Putnam, JB Jr., and Pollock, R.E., Patel, S.R., Fidler, I.J., and Benjamin, R.S. Treatment of the patient with lung metastases, Curr. Probl. Surg., 33:881 - 952, 1996. PMID:8909328

18. Putnam, JB Jr., The mediastinum: overview and diagnostic approach. In: J. Fishman, M.A. Grippi, L.R. Kaiser, and R.M. Senior (eds.), Pulmonary Diseases and Disorders, pp. 1469 - 1484, Ontario, Canada, B.C. Decker Inc. Publisher, 1997.

19. Putnam, JB Jr., Morris, P.*, and Roth, J.A. Esophageal Carcinoma. In: A.W. Silberman, and H. Silberman (eds.), Difficult Problems in Surgical Oncology, New York, Chapman & Hill, 1997.

20. Putnam, JB Jr., Surgery for pulmonary metastases. In: Advanced Therapy in Thoracic Surgery. K.L. Franco, and Putnam, JB Jr. (eds.), Ontario, Canada, B.C. Decker Inc., Publisher, 1997.

21. Swisher, S.G., and Roth, J.A. Role of gene therapy in lung cancer. In: L.L. Franco, and Putnam, JB Jr. (eds.), Advanced Therapy in Thoracic Surgery, pp. 139 - 145, Ontario, Canada, B.C. Decker, Inc., 1998.

22. Putnam, JB Jr., Pulmonary resection for metastatic diseases. In: H. Silberman, and A.W. Silberman (eds.), Problems in Surgical Oncology, New York, Chapman & Hill, 1999.

23. Putnam, JB Jr., Secondary tumors of the lungs. In: T.W. Shields (Hon.), J. LoCicero, III, and R.B. Ponn (eds.), General Thoracic Surgery, Fifth Edition, pp. 1555 - 1576 Philadelphia, Pennsylvania, Lippincott Williams & Wilkins, 1999.

24. Putnam, JB Jr. Lung (Including Pulmonary Embolism and Thoracic Outlet Syndrome). In: Sabiston Textbook of Surgery: The biological basis of modern surgical practice, 16th Edition. C.M. Townsend, Jr., R.D. Beauchamp, B.M. Evers, and K.L. Mattox (eds.), pp. 1205 - 1242, Philadelphia, Pennsylvania, W.B. Saunders Company, 2000.

25. Putnam, JB Jr., Metastatic cancer to the lung. In: Cancer: Principles and Practice of Oncology, Sixth Edition. V.T. DeVita, Jr., S. Hellman, and S.A. Rosenberg (eds.), pp. 2670 - 2686, Philadelphia, Pennsylvania, Lippincott Williams & Wilkins, 2001.

26. Putnam, JB Jr., and Roth, J.A. Pulmonary metastases. Surgical Oncology. H. Silberman and A.W. Silberman (eds.), pp. 742 - 764, London, Arnold Publishers, 2002.

27. Putnam, JB Jr., Post - resection Follow - Up for Non - Small Cell Lung Cancer. Thoracic Surgery 2nd Edition. F.G. Pearson, J.D. Cooper, J. Deslauriers, R.J. Ginsberg, C.A. Hiebert, G.A. Patterson, and H.C. Urschel, Jr. (eds.), pp. 918 - 924, Philadelphia, Pennsylvania, Churchill Livingstone, 2002.

28. Putnam, JB Jr., Implementation of multidisciplinary care in the treatment of patients with lung cancer. M. D. Anderson Cancer Care Series: Lung Cancer, F.V. Fossella, and R. Komaki (eds.), pp. 1 - 24, New York, Springer - Verlag, 2003.

28


Joe B. Putnam, Jr., M.D. Rev. December 201229. Putnam, JB Jr., Palliative care in patients with lung cancer. M. D. Anderson Cancer Care Series: Lung Cancer, F.V.

Fossella, and R. Komaki (eds.), pp. 220 - 240, New York, Springer - Verlag, 2003.Book Chapters (cont.)

30. Putnam JB Jr., Lung, Chest Wall, Pleura, and Mediastinum, Sabiston Textbook of Surgery, 19th Edition, pp. 1564-1610, 2012.

31. Ajani, J., Burak, W. E., D'Amico, T. A., Douglas, H. O., Eisenberg, B. L., Fuchs, C., Goldberg, M., Hayman, J. A., Javie, M., Karl, R. C., Koczywas, M., Kurtz, R. C., Locker, G. Y., Meropol, N. J., Minsky, B., Orringer, M. B., Posey, J. A., Putnam, JB Jr., Roth, J. A., Sasson, A. R, and Wood, D. E. Esophageal Cancer. Winn, R. J. NCCN Practice Guidelines in Oncology (http://www.nccn.org) V.1.2003, 1 - 22. 2003. Rockledge, PA, National Comprehensive Cancer Network.

32. Putnam, JB Jr., Lung (including pulmonary embolism and thoracic outlet syndrome). In Sabiston Textbook of Surgery (17th edition), pp 1763–1812. Townsend CM Jr., Beauchamp RD, Evers, BM, Mattox, KL (Eds.). Elsevier Saunders, Philadelphia, 2004.

33. Antevil JL*, Putnam JB Jr., Evaluation of the Patient with a diagnosis of non-small cell lung carcinoma. In New Treatment Paradigms in Non-Small-Cell Lung Cancer. Sandler AB (Ed), pp. 95–120, CMP Medica, New York, 2006.

34. Karamichalis JM*, Putnam, JB Jr., Lambright ES. Cardiovascular Complications after Lung Surgery. Thorac Surg Clin 16: 253 - 260, 2006. PMID:17004553

35. Putnam, JB Jr., Lung and Bronchus. In Textbook of Surgical Oncology, pp. 77–92. Poston GJ, Beauchamp RD, Ruers R (eds.); Informa Healthcare, London, 2007.

36. Smythe WR, Reznik SI, Putnam, JB Jr., Lung (including pulmonary embolism and thoracic outlet syndrome). In Sabiston Textbook of Surgery (18th edition), pp. 1698–1748. Townsend CM Jr., Beauchamp RD, Evers BM, Mattox KL (Eds.). Elsevier Saunders, Philadelphia, 2008.

37. Putnam, JB Jr., Postresection Follow-up for Non-Small Cell Lung Cancer. In Pearson’s Thoracic and Esophageal Surgery (3rd edition), pp. 790-795. Patterson GA, Cooper JD, Deslauriers J, Lerut AEMR, Luketich JD, Rice TW. Churchill Livingstone Elsevier, Philadelphia, 2008.

38. Putnam JB Jr. Outcomes of surgery for chest wall sarcomas. Thorac Surg Clin. 2010 Nov; 20(4): 535-542. PMID:20974437

39. Putnam JB Jr. Lung (including pulmonary embolism and thoracic outlet syndrome). In Sabiston Textbook of Surgery (19th edition, In Press, 2012) Townsend CM Jr., Beauchamp RD, Evers BM, Mattox KL (Eds.). Elsevier Saunders, Philadelphia.

40. Putnam, JB Jr. “Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer”. In Abeloff’s Clinical Oncology, Elsevier, Philadelphia, (Fifth Edition, In Press, 2012).

Books (edited and written)

1. Franco, K.L., and Putnam, JB Jr., (eds.), Advanced Therapy in Thoracic Surgery, Hamilton, Ontario, Canada, B.C. Decker, Inc., 1998.

2. Toledano A.Y., Olak, J., Statistical Techniques and Analysis in Thoracic Surgery. Franco, K.L., Putnam, JB Jr., editors, 1st ed. Hamilton, Ontario, Canada: B.C. Decker, p. 146, 1998.

3. Nesbitt, J.C. Walsh, G.L. Surgical Management of Esophageal Perforation; Advanced Therapy in Thoracic Surgery, Franco, K.L., Putnam, JB Jr., editors. Hamilton, Ontario, Canada: B. C. Decker, pp. 500-11, 2001.

4. Nesbitt, J.C., and Wind, G.G. (Eds.). Thoracic Surgical Oncology: Exposures and Techniques. Lippincott Williams and Wilkins, New York, 2003. Consulting Editors: Deslauriers, J., Faber, L.P., Ginsberg, R.J., Moores, D.W.O., Orringer, M.B., Paterson, G. A., Putnam, JB Jr., Rice, T.W., Rusch, V.W., Stewart, J.R., Walsh, and G.L.

5. Fossella, F.V., Komaki, R., and Putnam, JB Jr., Lung Cancer: M.D. Anderson Cancer Care Series. 2003. Series Editors Buzdar, A.U., and Freedman, R.S.

6. Franco, K.L. and Putnam, JB Jr., Advanced Therapy in Thoracic Surgery 2/e. May 2005. BC Decker Publishers.

Letters to the Editor

1. Baciewicz, F.N., Putnam, JB Jr., Naunheim, KS, and Kaiser, LR. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma - Discussion. J Thor Cardiovasc Surg, 112:1547 - 1548, 1996. PMID:8975846

2. Mathisen, D.J., Landreneau, R., Putnam, JB Jr., and Trastek, V.F. Acute and chronic morbidity differences between muscle-sparing and standard lateral thoracotomies - Discussion. J Thor Cardiovasc Surg, 112:1350 - 1351, 1996. PMID:8911333

29

http://www.ncbi.nlm.nih.gov/pubmed?term=Acute%20and%20chronic%20morbidity%20differences%20between%20muscle-sparing%20and%20standard%20lateral%20thoracotomies

http://www.ncbi.nlm.nih.gov/pubmed?term=Isolated%20lung%20perfusion%20with%20melphalan%20for%20the%20treatment%20of%20metastatic%20pulmonary%20sarcoma%20-%20Discussion.%20J%20Thor%20Cardiovasc%20Surg%2C%20112%3A1547%20-%201548%2C%201996



Joe B. Putnam, Jr., M.D. Rev. December 20123. Miller, J.I., Wright, and Putnam, JB Jr., Post-pneumonectomy bronchopleural fistula after sutured bronchial closure

- incidence, risk factors, and management - Discussion. J Thor Cardiovasc Surg, 112:1371, 1996. 4. Swisher, S.G., and Putnam, JB Jr., Influence of lymph node dissection on survival in esophageal cancer. J Surg

Oncol, 69:117 - 8, 1998. PMID:98085175. Putnam, JB Jr., Lung Cancer. Semin. Surg. Oncol., 18: 89-90, 2000. PMID:10657909

Manuals, Teaching Aids, Other Publications

1. Putnam, JB Jr., and Roth, J.A. Resection of pulmonary metastases from patients with osteogenic and soft tissue sarcomas. Medical Portfolio for Cardiovascular and Thoracic Surgeons, Vol. A, No. 2, 1983.

2. Putnam, JB Jr., Sweeney, M.S., Papadapolous, N.E.J., Melissinos, E.M., and Williams, J.P. En bloc resection of a mediastinal malignant fibrous histiocytoma with aortic arch reconstruction. Am Col Surg, Symposium on Spectacular Problems in Surgery, San Francisco, CA, 1990.

3. Putnam, JB Jr., Sweeney, M.S., Papadapolous, N.E.J., Melissinos, E.M., and Williams, J.P. En bloc resection of a mediastinal malignant fibrous histiocytoma with aortic arch reconstruction. Surgical Motion Pictures, Soc Thorac Surg, Orlando, FL, 1992.

4. Putnam, JB Jr., and Roth, J.A. Resection of pulmonary metastases from patients with osteogenic and soft tissue sarcomas. Medical Portfolio for Cardiovascular and Thoracic Surgeons, Vol. A, No 2, 1983.

5. Putnam, JB Jr., Soysal, O., Roth, J.A., Walsh, G.L., Nesbitt, J.C., and Schrump, D.S. Results of esophagectomy for severe dysplasia in Barrett’s esophagus. International Society for Diseases of the Esophagus (ISDE) Video - Library, Milan, Italy, 1996.

6. Putnam, JB Jr., “Managing Cancer”, video-based educational program outline for the public on breast, cervical, colorectal and lung cancer; FYI/Now, in conjunction with Society of Surgical Oncology, 2006.

7. Putnam, JB Jr., Walsh, G.L., Nesbitt, J.C., McMurtrey, M.J., Roth, J.A., Suell, A., Schrump, D.S., Ohnmacht, G.A. and Willis, K.M. The technique of esophagectomy does not influence survival after resection of esophageal carcinoma. 6th World Congress of the International Society of Diseases of the Esophagus (ISDE), Video - Library, Milan, Italy, 1996.

8. Putnam, JB Jr., Prospective Database for Thoracic Surgical Oncology, 1998.9. Putnam, JB Jr., Walsh, GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Smythe WR, Merriman KW, DeFord

LL. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Center for Reviews and Dissemination, National Health Service, Economic Evaluation Database. 2004. Document number 289876.

10. Dellinger, EP, Gordon, SM, Blackshear, RH, Putnam, JB Jr., Crosby CT, Foor, JS, Botte, MJ, Culligan P. Special Report: Surgical- ssociated Infection in Today’s Operating Room. Medi-Flex. McMahan Publishing Group, July, 2006.

11. Altorki N, Bunn PA Jr, Langer CUJ, Ota D, Putnam JB Jr. Tailoring the Treatment of Non-Small Cell Lung Cancer (NSCLC): From the surgeon to the Oncologist. Medical Education Resources, Inc., Curry Rockefeller Group/Oncology. (CME program content/education material development), 2007.

Other

National Comprehensive Cancer Network, NCCN Practice Guidelines for Esophageal Cancer, 2000.

EDITORIAL AND REVIEW ACTIVITIES:

Editorial BoardJournal of the American College of SurgeonsTurkish Journal of Thoracic and Cardiovascular Surgery

Journal ReviewerAnnals of Thoracic SurgeryAnnals of Surgical OncologyAssociazione Italiana per la Ricerca sul Cancro (AIRC)CancerCancer Immunology Immunotherapy Cancer BulletinChestCirculation

30



Joe B. Putnam, Jr., M.D. Rev. December 2012Clinical Cancer ResearchHead and NeckInternational Journal of Radiation OncologyJournal of the American College of SurgeonsJournal of Clinical OncologyJournal of Surgical Oncology

Journal Reviewer (cont.)

Journal of Surgical ResearchJournal Thoracic & Cardiovascular SurgeryMilitary MedicineNew England Journal of MedicineSurgerySurgical Laparoscopy Endoscopy and Percutaneous Techniques

OtherBayer Fellowship Selection Committee – 2007

STUDY SECTIONMember, F - 10 Study Section (diverse pre - , post - and senior post - doctoral applications, including those from respiratory, cardiovascular, nephrology, gastroenterology, bone biology, bioengineering, genetics, signaling, etc.) (2006)

Presentations at National or International Conferences

1. Walter Reed Army Medical Center - Thoracic Rounds, Diagnosis and Surgical Management of Gastroesophageal Reflux and its Complications, 9/89.

1. National Naval Medical Center, General Surgery Grand Rounds, Gastroesophageal Reflux, Bethesda, MD, 9/98.2. General Surgery Conference - Results of Pulmonary Surgery for Metastatic Sarcomas, 2/90. 3. Department of General Surgery Grand Rounds - Pulmonary Resection for Metastases, 2/90.4. Hillcrest Baptist Medical Center Cancer Seminar, Limits of Surgical Resection for Primary Carcinoma of the Lung,

4/90.5. The University of Iowa Surgery Grand Rounds, The Limits of Surgical Resection for Carcinoma of the Lung. 6/90.6. United States Naval Hospital Family Practice Grand Rounds, The Diagnosis and Management of Gastroesophageal

Reflux, Twenty - Nine Palms, CA, 7/90.7. Department of Pediatrics Grand Rounds - Prognostic Indicators for Survival Following Resection of Pulmonary

Metastases, 7/90.8. University of Tennessee at Memphis, Surgical Grand Rounds, Management of Pulmonary Metastases, 9/91.9. Association of Military Surgeons of the United States, Back - fill Experiences During Operation Desert Storm, San

Antonio, TX, 11/91.10. The Society of Surgical Oncology Laparoscopic/Thoracoscopic Symposium, 46th Annual Meeting, Thoracoscopic

Resection of Pulmonary Tumors, Los Angeles, CA, 3/93.11. North Florida Hematology and Oncology Associates, St. Vincent’s Medical Center Cancer Education Seminary,

Cancer of the Esophagus, Jacksonville, FL, 5/93.12. Congress on Laparoscopy, Thoracoscopy, and Pelvioscopy, Video - assisted Thoracoscopy Istanbul, Turkey, 11/93.13. Congress on Laparoscopy, Thoracoscopy, and Pelvioscopy, Surgical Management of Esophageal Cancer, Istanbul,

Turkey, 11/93.14. Bethesda Memorial Center, Annual Cancer Conference of The Center for Radiation Oncology, Surgical

Management of Esophageal Cancer, West Palm Beach, FL, 11/93.15. Baptist Hospital of Southeast Texas Cancer Symposium, Video - assisted Thoracic Surgery, Beaumont, TX, 11/93.16. Baptist Hospital of Southeast Texas Cancer Symposium, Current Management of Esophageal Carcinoma,

Beaumont, TX, 11/93.17. Society of Surgical Oncology 47th Annual Cancer, Symposium Surgery for Metastatic Disease - Resection of

Pulmonary Metastases, 3/94.18. 81st Annual Meeting of the Texas Radiologic Society, Carcinoma of the Esophagus, Austin, TX, 4/94.19. 4th European Congress of Video Surgery, Application of V.A.T.S. Techniques in Thoracic Oncology, Istanbul,

Turkey, 6/94.20. 4th European Congress of Video Surgery, Thoracic Resection of Pulmonary Metastases, Istanbul, Turkey, 6/94.

31

Joe B. Putnam, Jr., M.D. Rev. December 201221. 4th European Congress of Video Surgery, Thoracoscopy in the Staging and Treatment of Esophageal Carcinoma:

Comment and Controversies, Istanbul, Turkey, 6/94.22. 4th European Congress of Video Surgery, Risks and Complications in Video Surgery, Istanbul, Turkey, 6/94.23. 3rd United States/Japan Clinical Trial Summit, Southwest Oncology Group, Treatment of Pulmonary Metastases,

Seattle, WA, 8/94.24. Balboa Alumni of General Surgery Conference, Naval Medical Center. The Surgical Management of Esophageal

Carcinoma: University of Texas M.D. Anderson Cancer Center Experience, San Diego, CA, 10/94.

Presentations at National or International Conferences (cont.)

25. St. Thomas Regional Hospital, Perioperative Chemotherapy and Surgery in Stage III, Non - small Cell Lung Cancer, Norman, OK, 10/94.

26. Current Management of Pulmonary Disease: Pleural Disorders Symposium Management of Malignant Pleural Effusion, St. Thomas Medical Center at Vanderbilt, Health Education Services, Laurence A. Grossman Medical Learning Center, Nashville, TN, 10/94.

27. Bethesda Memorial Hospital 9th Annual Clinical Cancer Conference, Current Trends in the Treatment of Carcinoma of the Lung, Surgical Management of Carcinoma of the Lung, Boynton Beach, FL, 11/94.

28. Our Lady of the Lake Regional Medical Center, Management Update in Resectable Non - small Cell Lung Cancer, Baton Rouge, LA, 11/94.

29. Bay Area Tumor Institute, Lung Conference, Current Therapies in the Treatment of Non - small Cell Lung Cancer, Oakland, CA, 2/95.

30. Baptist Hospital Cancer Conference, Pensacola, FL., 2/95.31. General Thoracic Surgical Club 1995 Meeting, Resection of Pulmonary Metastases, South Seas Plantation Resort &

Yacht Harbor, Captiva Island, FL, 3/95.32. St. John’s Hospital, Oncology Symposium, Combined Modality Treatment of Non - small Cell Lung Cancer, Detroit,

MI, 9/95.33. International Workshop of Lung Metastases, National Heart and Lung Institute, Role of VATS, London, England,

10/95.34. International Workshop of Lung Metastases, Soft Tissue Sarcomas, National Heart and Lung Institute, London,

England, 10/95.35. International Workshop of Lung Metastases, VATS, Panel Discussion, National Heart and Lung Institute, London,

England, 10/95.36. Invited Speaker, Argentine Congress of Pneumology, Lung Cancer and VATS, Buenos Aires, Argentina, 10/95.37. Invited Speaker, Argentine Congress of Pneumology, Present Indications and Future Projections of VATS, Buenos

Aires, Argentina, 10/95.38. Invited Speaker, Argentine Congress of Pneumology, VATS in Lung Cancer, Buenos Aires, Argentina, 10/95.39. International Society of Diseases of the Esophagus, Results of Esophagectomy for Severe Dysplasia in Barrett’s

Esophagus, Milan, Italy, 1995.40. International Society Diseases of The Esophagus, The Technique of Esophagectomy Does Not Influence Survival

After Resection of Esophageal Carcinoma, Milan, Italy, 1995.41. Society of Thoracic Surgeons 32nd Annual Meeting, Resecting the Unresectable Thoracic Neoplasm, Orlando, FL,

1/96.42. Wayne State University, Harper Hospital Oncology Grand Rounds, The Role of Surgery in the Management of

Esophageal Carcinoma, Detroit, MI, 3/96.43. Wayne State University, Harper Hospital Lung Cancer Academic Conference, Neoadjuvant Chemotherapy Plus

Surgery in the Treatment of Potentially Resectable Non - small Cell Lung Cancer, Detroit, MI, 3/96.44. IASLC Workshop, Limits of a Surgical Resection for Stage III Non - small Cell Lung Cancer, Brussels, Belgium,

6/96.45. Harvard Medical School, Minimally Invasive Thoracic Surgery Interest Group International Symposium, Role of

Minimally Invasive Surgery for Sub - lobar Pulmonary Resection of Peripheral Lung Cancer, Boston, MA, 9/96.46. Henry Ford Hospital Oncology Grand Rounds, Multimodality Treatment of Advanced Stage Lung Cancer: Surgery

and Neoadjuvant Chemotherapy, Detroit, MI, 9/96.47. East Texas Lung Symposium, Neoadjuvant Therapy of Lung Cancer, Tyler, TX, 9/96.48. Memorial Regional Cancer Center, 12th Annual Symposium, Perspectives in Cancer, Diagnosis and Treatment,

Modesto, CA, 9/96.49. Invited Discussant for Burt, M. and Gold, J. American College of Surgeons, Pulmonary Metastatectomy with Removal

of Tumor Invading the Left Atrium: Sequential Approach, Thoracic Surgery Cline Clinics, San Francisco, CA, 10/96.

32

Joe B. Putnam, Jr., M.D. Rev. December 201250. The Royal Academy of Surgery and Medicine of Galacia, Video - assisted Thoracic Surgery: University of Texas

M.D. Anderson Cancer Center Experience, LaCoruna, Spain, 10/96.51. Metástasis Pulmonares. III Reunión del Area de Oncologia de la Sociedad Espanola de Neumologia y Cirugia

Torácica (SEPAR), Surgical Management of Pulmonary Metastases, LaCoruna, Spain, 10/96.52. John Alexander Society Meeting, Changing Roles in Thoracic Surgery, Ann Arbor, MI, 11/96.53. Caraway Cancer Center Cancer Symposium, The Surgical Treatment of Non - small Cell Lung Cancer During the

Multimodality of Treatment of Non - small Cell Lung Cancer, Birmingham, AL, 12/96.


54. 2nd Andorran Congress on Lung Cancer, Neoadjuvant Chemotherapy in Non - small Cell Lung Cancer, Andorra, Spain, 2/97.

55. Society of Thoracic Surgery Meeting, U - 10 Steering, MDACC ID91 - 025 - Phase III Double - blind Randomized Trial of 13 - cis Retinoic Acid to Prevent Second Primary Tumors in Stage I Non - small Cell Lung Cancer, San Diego, CA, 2/97

56. Neurosciences/Oncology Symposium, Into the 21st Century: The Treatment of Advanced Stage Lung Cancer: Surgery/Chemotherapy/Gene Therapy, California Cancer Center, Monterey, CA, 3/97.

57. New Mexico Society Clinical Society, Multimodality Treatment of Small - cell Lung Cancer, Albuquerque, NM, 4/97. 58. American Association for Thoracic Surgery, Surgery for Pulmonary Metastases, Washington DC, 5/97.59. American Association Thoracic Surgeons General Thoracic Surgery Symposium, Surgery for Metastatic Disease to

the Lung, Washington DC, 5/97. 60. Chest South Africa 1997 Conference, Neoadjuvant Chemotherapy and Surgery in the Treatment of Lung Cancer,

Windhoek Namibia, South Africa, 9/97.61. Chest South Africa 1997 Conference, The Surgical Management of Esophageal Carcinoma, Windhoek Namibia, South

Africa, 9/97.62. Chest South Africa 1997 Conference, Pulmonary Metastases: A Multidisciplinary Approach, Windhoek Namibia,

South Africa, 9/97.63. Pulmonology Society Congress, Current Management of Advanced Stage Lung Cancer Windhoek Namibia, South

Africa, 9/97.64. ‘8th World Conference on Lung Cancer. The Role of Thoracoscopy in the Diagnosis and Staging of Lung Cancer,

Dublin, Ireland, 10/97.65. 1st International Symposium in Current Concepts in Lung Cancer and Future Considerations for the XXI Century,

Surgical Treatment of Advanced Lung Carcinoma: Into the 21st Century, Madrid, Spain, 11/97.66. 3rd Annual Scientific Meeting Connective Tissue Oncology Society, Isolated Single Lung Perfusion with Adriamycin

for Unresectable Sarcomatous Metastases, Milan, Italy, 11/97.67. Austin Surgical Society, Esophageal Cancer: What is the Right Operation? Austin, TX, 1/98.68. Pittsburgh Thoracic Surgical Society, Evolving Management of Pulmonary Metastases, Pittsburgh, PA, 3/98.69. Facing the Challenges of NSCLC: Innovations in Combined - Modality Treatment Strategies, Non - Small Cell Lung

Cancer: Defining the Problem, Staging, and Surgical Management, San Diego, CA, 4/98.70. Facing the Challenges of NSCLC: Innovations in Combined - Modality Treatment Strategies, Non - Small Cell Lung

Cancer: Defining the Problem, Staging, and Surgical Management, Los Angeles, CA, 4/98.71. Facing the Challenges of NSCLC: Innovations in Combined - Modality Treatment Strategies, Non - Small Cell Lung

Cancer: Defining the Problem, Staging, and Surgical Management, Birmingham, AL, 4/98.72. Cancer Initiative 2000, Surgical Options in Non - Small Cell Lung Cancer, Dallas, TX, 4/98.73. American Radium Society Annual Meeting, New Approaches for a New Millennium, Non - Small Cell Lung Cancer

Case Panel, Monte Carlo, Monaco, 5/98.74. Visiting Professor Lectureship Series, Allegheny General Hospital, Edward M. Kent, M.D., Pittsburgh, PA, 5/98.75. Institute for Continuing Healthcare Education: Facing the Challenges of NSCLC: Innovations in combined -

Modality Treatment Strategies, Non - Small - Cell Lung Cancer: Defining the Problem, Staging, and Surgical Management, Washington DC, 6/98.

76. Institute for Continuing Healthcare Education: Facing the Challenges of NSCLC: Innovations in combined - Modality Treatment Strategies, Non - Small - Cell Lung Cancer: Defining the Problem, Staging, and Surgical Management, Atlanta, GA, 6/98.

77. Institute for Continuing Healthcare Education: Facing the Challenges of NSCLC, Non - Small - Cell Lung Cancer: Defining the Problem, Staging, and Surgical Management, Oklahoma City, OK, 6/98.

78. Lorain County Physicians/Community College Continuing Medical Education Consortium, Annual Pulmonary/Critical Care Seminar: Multi - Modality Treatment of Lung Cancer, Cleveland, OH, 9/98.

33

Joe B. Putnam, Jr., M.D. Rev. December 201279. Institute for Continuing Healthcare Education: Facing the Challenges of NSCLC, Non - Small - Cell Lung Cancer:

Defining the Problem, Staging, and Surgical Management Buffalo, New York, 9/98.80. Logical Communications, Inc.: Multimodality Approach to the Management of Malignancies of the Thorax, Non -

Small - Cell Lung Cancer: Defining the Problem, Staging, and Surgical Management Role of Surgery in NSCLC and the Revised Staging System, San Antonio, TX, 10/98.

81. 5th National Thoracic and Cardiovascular Surgery Conference, Neoadjuvant Chemotherapy and Surgery in the Multimodality Treatment of Lung Cancer, Antalya, Turkey, 10/98.

82. American College of Surgeons Annual Clinical Congress, Optimal Management of Malignant Effusions, Orlando, FL, 10/98.


83. American College of Surgeons Annual Clinical Congress, Massive Mediastinal Tumors - A Surgical Dilemma, Orlando, FL. 10/98

84. XXXI World Congress of the International College of Surgeons, Mediastinal Tumors, Buenos Aires, Argentina, 11/98.85. XXXI World Congress of the International College of Surgeons, Treatment of Pulmonary Metastases, Buenos Aires,

Argentina, 11/98.86. XXXI World Congress of the International College of Surgeons, Adjuvant Therapy in Advanced Pulmonary Cancer,

Buenos Aires, Argentina, 11/98. 87. XXXI World Congress of the International College of Surgeons, Pleural Mesothelioma, Buenos Aires, Argentina,

11/98.88. XXXI World Congress of the International College of Surgeons, Indications in Thoracic Pathology, Buenos Aires,

Argentina, 11/98. 89. XXXI World Congress of the International College of Surgeons, Current State in the Surgical Treatment in Pulmonary

Cancer, Buenos Aires, Argentina, 11/98.90. Southern Thoracic Surgical Association, Early Cost Comparison between Tube Thoracostomy vs. Chronic Indwelling

Pleural Catheter (Pleurx) For Treatment of Malignant Pleural Effusion, Orlando, FL, 11/98.91. Emory University Conference, The Role of Surgery and Neoadjuvant Chemotherapy in the Management of Advanced

Stage Lung Cancer, Atlanta, GA, 11/98.92. RSNA 1998 84th Scientific Assembly & Annual Meeting, Management Lung Cancer, Chicago, Ill, 12/98.93. The Society of Thoracic Surgeons 35th Annual Meeting, An Aggressive Multidisciplinary Surgical Approach to

Superior Sulcus Tumors with Vertebral Invasion Can Lead to Long - Term Survival, San Antonio, TX, 1/99.94. 11th Annual MASCC International Symposium Meeting, Chronic Indwelling Pleural Catheter (Pleurx®) for Cost

Effective Management of Malignant Pleural Effusions, Nice, France, 2/99.95. WellStar Promina Northwest Professional Cancer Education Program, Multimodality Approach in the Treatment of

Lung Cancer, Marietta, GA, 3/99.96. Madigan Army Medical Center Grand Rounds and Chest Conference, The Multimodality Approach to Lung Cancer

Tacoma, WA, 3/99.97. Visiting Professor, University of Toronto/Ontario Cancer Institute/Princess Margaret Hospital, Thoracic Oncology

Tumour Conference, Evolving Management of Malignant Pleural Effusions Toronto, Ontario, Canada, 4/99.98. American Radium Society 81st Annual Meeting Esophagus Panel: Current Multidisciplinary Management for Cancer

of the Esophagus, Role of Surgery for Esophageal Cancer, Big Island of Hawaii, 4/99.99. Japan/U.S. Cancer Therapy Symposium Post American Radium Society Meeting, Surgical Management for

Carcinoma of the Esophagus: University of M.D. Anderson Cancer Experience, Hiroshima, Japan, 4/99.100. The Multidisciplinary Management of Thoracic Malignancies, Evolving Role of Surgery in the Management of

Carcinoma of the Lung, Istanbul, Turkey, 6/99.101. The Multidisciplinary Management of Thoracic Malignancies, Management of Malignant Pleural Effusions, Istanbul,

Turkey, 6/99.102. 85th Annual Clinical Congress of the American College of Surgeons, Pulmonary Metastases San Francisco, CA 10/99.103. 1999 Annual Clinical Assembly of Osteopathic Specialists, Multimodality Treatment of Lung Cancer, Seattle, WA,

10/99.American Society for Therapeutic Radiology and Oncology 41st Annual Meeting, New Surgical Approaches in NSCLC, San Antonio, TX, 10/99.

104. 46th Annual Meeting Southern Thoracic Surgical Association, Thoracoscopy has a Limited role in Lung Surgery Especially in Malignant Disease, San Juan, Puerto Rico, 11/99.

105. RSNA 85th Scientific Assembly and Annual Meeting, Diagnosis and Multidisciplinary Approach for Lung Cancer, Chicago, ILL, 12/99.

106. Chest Disease Management Conference, Management of Malignant Pleural Effusion, Nashville, TN, 12/99.

34

Joe B. Putnam, Jr., M.D. Rev. December 2012107. SPIE’s BiOS 2000 The International Symposium on Biomedical Optics, Therapeutic Considerations of Heat - Induced

Lung Injury, San Jose, CA 1/00.108. General Thoracic Surgical Club 13th Annual Meeting, Super Bowl of X - Rays, Tucson, AZ, 3/00.109. American Association of Thoracic Surgeons, Malignant Pleural Effusion, Toronto, Canada, 4/00.110. 25th Year Lung Days, General Thoracic Surgery Course, Pulmonary Metastasectomy, Istanbul, Turkey, 5/00.111. 25th Year Lung Days, General Thoracic Surgery Course, How To Do Research in Thoracic Surgery, Istanbul, Turkey,

5/00.112. 25th Year Lung Days, General Thoracic Surgery Course, Management of Patients with Malignant Pleural Effusions

Istanbul, Turkey, 5/00.113. 25th Year Lung Days, General Thoracic Surgery Course, Pre - and Intra - operative Evaluation of Patients Undergoing

Lung Resection Following Neo - adjuvant Chemotherapy for Lung Cancer, Istanbul, Turkey, 5/00.


114. 36th Annual ASCO Educational Symposia Meeting, Multidisciplinary Approach to the Management of Soft - Tissue Sarcomas, New Orleans, LA, 5/00.

115. Scientific Advisory Board Meeting, Santa Fe, NM, 7/00116. 2nd Annual Lung Outing, Neo Adjuvant Therapy NSCLC Multi - Modality Treatment of Lung Cancer, Oregon, OH,

8/00.117. Illinois Thoracic Society Meeting, Induction Chemotherapy and Surgery for NSCLC, Chicago, IL, 9/00. 118. MedSourceOne Continuing Education Program, Multimodality Treatment of Lung Cancer, Joplin, MO, 10/00. 119. 6th Turkish Thoracic and Cardiovascular Association Congress, The Clinical Basis for Surgery and Multidisciplinary

Care in the Patient with Lung Cancer, Antalya, Turkey, 10/00.120. Southern Thoracic Surgical Association 47th Annual Meeting, Marco Island, FL, 11/00. 121. Columbus Community Clinical Oncology Program, Neoadjuvant Chemotherapy and Surgery for Early Stage Lung

Cancer, Dublin, OH, 11/00.122. Tumor Conference, Neoadjuvant Chemotherapy and Surgery for Early Stage Lung Cancer, Wheeling, WV, 12/00.123. Society of Thoracic Surgeons Meeting, National Database for Thoracic Surgeons, New Orleans, LA, 1/01.124. International Workshop for Lung Cancer Database Meeting, London, 2/01.125. General Thoracic Surgical Club, Clinical Trials Meeting, Captiva Island, FL, 3/01.126. The University of Texas M. D. Anderson Cancer Center, Conversations about Cancer Research, Naples, FL, 3/01.127. Japan/US Cancer Therapy Symposium, the Evolution of Neoadjuvant Therapy for Esophageal Carcinoma: University

of Texas M. D. Anderson Cancer Center Experience, La Jolla, California, 4/01.128. American Radium Society Meeting, Moderate session on Chest, Coronado, CA, 4/01.129. The American Association for Thoracic Surgeons 81st Annual Meeting, Vertebrectomy and Reconstruction for Tumors

Invading the Spine, San Diego, CA, 5/01.130. STS Coding Workshop Meeting, Reimbursement for Thoracic surgeons: A “Political” Process, New Orleans, LA,

5/01.131. SCO Annual Meeting, PET Scanning in Resectable NSCLC, San Francisco, CA, 5/01.132. Bristol - Myers Squibb International Oncology Visiting Faculty Program, A Role for Pre - and Post - Adjuvant

Chemotherapy in early Stage NSCLC, Yokohama, Japan, 7/01.133. Tenth G. Rainey Williams Surgical Symposium, Management of Non - Small Cell Lung Cancer: Neoadjuvant,

Adjuvant or Neoadjuvant Support of Surgery, Oklahoma City, OK, 9/01.134. Mayo Clinic Grand Rounds, The Evolution of Multidisciplinary Therapy for Lung Cancer: University of Texas M. D.

Anderson Cancer Center Experience, Rochester, MN, 9/01.135. 87th Annual Clinical Congress of the American College of Surgeons, Surgical Techniques and Results of

Multimodality Therapy for Advanced Thymoma, New Orleans, LA, 10/01.136. 6th Annual Perspectives in Thoracic Cancer, Management of Malignant Pleural Effusions, New York, NY, 10/01.137. Thoracic Oncology Conference, Discussion of common and difficult lung cancer clinical scenarios, San Francisco,

CA, 11/01.138. Chest 2001 67th Annual International Scientific Assembly, Technical Challenges Pancoast, Carinal Resections and

Patient Selection for and Techniques of Metastasectomy, Philadelphia, PA, 11/01.139. STSA Annual Meeting, Coding and Reimbursement Workshop, San Antonio, TX, 11/01.140. Riverside Methodist Hospital Grand Rounds, Lung Cancer Management, Columbus, OH, 11/01.141. 1st SMCCC - MDACC International Joint Symposium, Advances in the Surgical Management of Lung Cancer, Seoul,

Korea, 12/01.142. 38th Annual STS Meeting, Thoracic Database, Fort Lauderdale, FL, 01/02.

35

Joe B. Putnam, Jr., M.D. Rev. December 2012143. Expanded Faculty Speaker Training Meeting, Inside Cancer: The Impact of EGFR - TK Inhibition on the Most

Common Solid Tumors, Boca Raton, FL, 2/02.144. IRESSA NSCL Advisory Board Meeting, Philadelphia, PA, 2/02.145. General Thoracic Surgical Club 15th Annual Meeting, Lung Cancer with Satellite Nodules: Staging and Management,

Tucson, AZ, 3/02.146. XXXIII Peruvian International Congress of Surgery Meeting, Massive Mediastinal Tumors, Neoadjuvant Therapy in

Cancer of the Lung, and Multimodality Treatment in Cancer of the Esophagus, Lima, Peru, 3/02.147. Round Table Discussion/Tumor Board Meeting, S9900 Clinical Trial and Current Staging from the ATSERS

Guidelines, Amarillo/Lubbock, TX, 4/02.148. NATCH Study Meeting, Ongoing US and EU Trials in Neoadjuvant/Adjuvant Chemotherapy in NSCLC, Madrid,

Spain, 4/02.149. ERS Research Seminar Isolated Lung Perfusion, ILP for Sarcomatous Metastases, Edegem, Belgium, 4/02.150. American Association for Thoracic Surgery, Managing Data: Thoracic Surgical Database Management, and Current

Role of Induction Therapy, Washington, DC, 5/02.


151. ACOSOG Semi - Annual Meeting, Audit Committee, Toronto, Canada, 6/02.152. IASLC Workshop Progress and Guidelines in the Management of Non Small Cell Lung Cancer, Induction Treatment

before Surgery for Stage I and II, Bruges, Belgium, 9/02.153. Duke UNC Lecture, Biology Basis for Multidisciplinary Management in Early and Locally Advanced Non Small Cell

Lung Cancer, Chapel Hill, NC, 9/02. 154. 7th Annual Perspectives in Thoracic Cancer, The Management of Malignant Effusion, and Palliative Surgery for

Specific Situations: Pancoast Tumors, Carinal Resections, Vertebral Invasion, New York, NY, 10/02. 155. 1st International Lung Cancer Conference, Surgical Advances for Locally Advanced Non - Small Cell Lung Cancer,

Beijing, China, 11/02.156. ACOSOG/DSMC Annual Meeting, Executive Committee, Chicago, IL, June 2004. 157. International Society of Gastrointestinal Oncology, Esophageal Cancer - Is Surgery Necessary for Cancer of the

Esophagus? Arlington, VA, July 2004.158. 17th Japan Chapter Congress of International Society of CT Surgery, The Surgical Management of Pulmonary

Metastasis, Tokyo, Japan, July, 2004.159. ACOSOG Mock Site Visit, Durham, NC, September 2004160. NCI Lung Cancer Intergroup Meeting, Committee Updates, Bethesda, MD, September 2004.161. Moderator, General Thoracic Track: Thoracic Surgery: 2010 & Beyond, STS/AATS Tech - Con Annual Meeting,

San Diego, CA, January 2007.162. American Board of Thoracic Surgery, Consultants Committee, Washington, DC, September 2004163. ACOSOG Site Visit, Durham, NC, October 2004.164. American College of Surgeons, Workforce meetings; Moderator - Postgraduate Course: Emerging Procedures in

General Thoracic Surgery; Presenter - Radiofrequency ablation of lung tumors, New Orleans, LA, October 2004.165. Society of Thoracic Surgeons National Database Event, The Past, Present and the Future of the General Thoracic

Surgery Database, Chicago, IL, October 2004.166. 45th Annual Meeting of Japan Lung Cancer Society, IASLC Workshop, Surgical Problems after induction

chemotherapy or chemoradiotherapy; Overview of resectable NSCLC - Evolving role of induction therapy; Perioperative evaluation of early stage NSCLC, Tokyo, Japan, October 2004.

167. 51st Annual Meeting Southern Thoracic Surgical Association, Surgical Approaches to Esophageal Carcinoma; Update on Coding, Cancun, Mexico, November 2004.

168. ACOSOG Executive Steering Committee, Chicago, IL, November 2004. 41st Annual Meeting of the Society of Thoracic Surgeons, Morbidity and Mortality of Major Pulmonary Resections in Patients with Early - Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial, Tampa, FL, January 2005.

169. ACOSOG Semiannual Meeting, Executive Committee; Thoracic Organ Site Committee, San Antonio, TX, January 2005.

170. Harvard School of Public Health Center for Continuing Professional Education, Programs for Chiefs of Clinical Services, Group Discussion Leader, Boston, MA, January 2005.

171. American Society of Clinical Oncology, Innovations in Mediastinal Staging & Response in Lung Cancer, Orlando, FL, May 13 and 15, 2005.

172. American Society of Clinical Oncology, Operable Esophageal Cancer: Therapeutic Strategies, Orlando, FL. May 16, 2005.

173. IASLC 11th World Conference on Lung Cancer, Discussant in Oral Sessions of Surgery Papers, Barcelona, Spain, July 2005.

36

Joe B. Putnam, Jr., M.D. Rev. December 2012174. IASLC 11th World Conference on Lung Cancer, Plenary Session - The Robert Ginsberg Lecture: Surgical Approaches

to Lung Cancer, Barcelona, Spain, July 2005.175. 4th Annual Symposium on Gastrointestinal Cancers: An update on advances in diagnosis and management.176. “Chemoradiation in esophageal cancer: Before/after/instead of surgery” St. Louis University, St. Louis, MO, October

1, 2005.177. Society of Thoracic Surgery 42nd Annual Meeting: Panel Moderator, “Frontiers in Diagnosis and Management”;

Presenter: “Endobronchial Ultrasound in Stating of Thoracic Malignancy”; Panel Moderator: “Advances in Management of Barrett’s Epithelium and Esophageal Cancer”, Chicago, IL, January, 2006.

178. Identification and Prevention of Surgical Site Infections (SSI) Roundtable, Medi - Flex, Inc., Dallas, TX, January, 2006.

179. General Thoracic Surgery Club, “Management of Malignant Pleural Effusions” Tucson, AZ, March 11, 2006180. Society of Thoracic Surgeons General Thoracic Surgery Symposium. “Resection for Lung Cancer” San Diego, CA,

January 28, 2007181. American Association for Thoracic Surgery General Thoracic Surgery Symposium, "Indwelling Pleural Catheters."

Philadelphia, PA, April 30, 2006.


182. West Japan Thoracic Oncology Group (WJTOG) 2nd International Symposium on Lung Cancer Clinical Trial”, Nara - Ken, Japan, July 7, 2006.

183. Kent Trinkle Lecture, Southern Thoracic Surgical Association, “History of Residency Education At Vanderbilt University”, Tucson, AZ, November 2006.

184. American Association of Thoracic Surgeons Annual Meeting. “Controversies in Cardiothoracic Surgery”, Washington, DC, May, 2007.

185. IASLC World Congress on Lung Cancer, “M19 - 01 Treatment of IIIA Overview”, Seoul, Korea, September, 2007. 186. Society of Thoracic Surgeons Annual Meeting, General Thoracic Surgery Symposium: “Revising the Staging System”; Ft.

Lauderdale, FL, January, 2008. 187. Japanese Association for Chest Surgery, “Beyond Mechanical Therapy: The Role of Adjuvant Chemotherapy for Non

- Small Cell Lung Carcinoma”; Utsunomiya, Japan, May, 2008.188. 2008 Evidence to Outcomes Conference, What’s Right in Healthcare; “Teaching Physician - Patient Communication

(AIDETSM) for Results in All Pillars”; The Studer Group, Atlanta, GA; June, 2008.189. 79th Argentine Congress on Surgery; Buenos Aires, Argentina; “Thymoma”, “Esophageal Cancer Treatment”, “Open

Thoracotomy v. VATS Resection for Lung Cancer. Are they the same from an oncological point of view?”, “Stage III Lung Cancer”, November 11 - 13, 2008.

190. Society of Thoracic Surgeons Annual Meeting, “Lung Cancer Staging: What’s Up?”, San Francisco, CA, January 23-28, 2009.

191. Sixth Annual Winter Lung Cancer Conference, “New Tools in Surgical Management of Lung Cancer”; Sunny Isles Beach, FL, March, 2009.

192. American Association for Thoracic Surgery Annual Meeting, “Non-small Cell Lung Cancer”, Boston, MA, May 9-11, 2009.

193. International Association of Lung Cancer Annual Meeting, “Adjuvant Chemotherapy: Stage Specific Discussion”, “Indications for and Outcomes of Surgery for Metastatic Disease, Primary Lung Cancer, and Mediastinal Nodal Involvement”, “Surgery for NSCLC: Node Dissections, outcome Analysis and VATS Surgery”, San Francisco, CA, July 31 – Aug 4, 2009.

194. International Lung Cancer Symposium, “Surgery in Locally-Advanced Disease”, “From Theory to Practice: Premature Disease”, “Surgical Controversies”, “State of the Art: Mesothelioma”, Sirio Libanes Hospital, Sao Paulo, Brazil, Sept 9-13, 2009.

195. ESTS School of Thoracic Surgery, Covidien European Training Center, “Minimally Invasive Lung Surgery and Associated Treatments Session: “Neoadjuvant and adjuvant treatments for resected NSCLC: Complications and Results, Elancourt, France; October 2009.

196. ESTS School of Thoracic Surgery, Covidien European Training Center, “Radiofrequency Ablation (RFA) and Cryotherapy (CR) for Pulmonary Session: Radiofrequency ablation (RFA) and Cryotherapy (CR) for pulmonary lesions: Indications of RFA”, “Techniques, complications and results of RFA”, Elancourt, France; October 2009.

197. American College of Surgeons Annual Meeting: “Current Therapeutics for High-Risk Patients; Non-Small Cell Lung Cancer: “Standard of Care is Lobectomy: Why not Wedge Resection?”, Chicago, IL; October 2009.

198. Society of Thoracic Surgeons Annual Meeting, Discussant, “J. Maxwell Chamberlain Memorial Paper for General Thoracic Surgery: Predictors of Mortality and Major Morbidity After Resection for Lung Cancer – A Society of Thoracic Surgeons General Thoracic Surgery Database Risk Model.; Ft. Lauderdale, FL; January 26, 2010.

37

Joe B. Putnam, Jr., M.D. Rev. December 2012199. Society of Thoracic Surgeons Annual Meeting, “Separating the wheat from the chaff: Is it time for a model that

predicts benign disease in patients with pulmonary nodules?”; Ft. Lauderdale, FL; January 26, 2010.200. European Lung Cancer Conference: “Controversy Session: Stage IIIA N2 NSCLC: Surgery has no role to play in

Stage III NSCLC”, Geneva, Switzerland, April 28, 2010.201. Yale Cancer Center “Novel Agents in the Treatment of Lung Cancer” CME Program; New Haven, CT, September, 2010.202. Southern Thoracic Surgical Association Annual Meeting. Discussant: “Oncologic Efficacy of Anatomic Segmentectomy in

Stage IA Non-Small Cell Lung Cancer Patients with T1a Tumors”, Orlando, FL, November, 2010.203. American Association of Thoracic Surgery Annual Meeting, “Completeness of Intra-operative Oncologic Staging and

Outcomes at the Time of Primary Lung Cancer Resection Varies by Surgeon Specialty”, San Diego, CA, January, 2011.

204. World Conference on Lung Cancer, “Surgery After Induction: When and How?”, Amsterdam, The Netherlands, July, 2011.

205. Fourth International Forum on Multidisciplinary Management of Lung Cancer, “Lung Cancer Management”, Beijing, China, December 2011.

206. American College of Surgeons Commission on Cancer Meeting, “Surgical Indications for Pulmonary Metastatectomy”, Chicago, IL, October, 2012.


207. American Association for Thoracic Surgery, Focus on Thoracic Surgery: Lung Cancer Symposium, “Pneumonectomy Post-Induction Therapy”, “Complications: Best Ways to Avoid and How to Handle Difficult Ones”, Boston, MA, November, 2012.

208. Southern Thoracic Surgical Association Annual Meeting, “Open, VATS and Robotic Lobectomy: review of a National Database”, “A Propensity Matched Comparison of Pleurodesis or Tunneled Pleural Catheter in Patients Undergoing Diagnostic Thoracoscopy for Malignancy”, Naples, FL, November, 2012.

Seminar Invitations from Other Institutions

Lectureships and Visiting Professorships

1. University of Tennessee Medical School, Memphis, TN , 19952. University of Toronto, Mount Sinai Hospital, 19953. Visiting Professor Lectureship Series, Allegheny General Hospital, Edward M. Kent, M.D., Pittsburgh, PA, 1998.4. University of Toronto/Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada, 4/99.5. The Mayo Clinic, Rochester, MN, 20016. The Carolinas Heart Institute, Carolinas Medical Center, Charlotte, NC, 20027. General Thoracic Surgery Visiting Professor, Rush Medical Center Grand Rounds, Chicago, IL, December, 20048. Scott & White Hospital, Temple, TX, April, 2005.9. The 2nd Annual Evelyn Grollman Glick Lectureship in Thoracic Surgery, Johns Hopkins Hospital, Baltimore, MD,

May 5, 200510. Craighead Visiting Professor, Louisiana State University, New Orleans, LA, May 10, 200511. Sommer Memorial Lectureship, Oregon Health Science University, Portland, OR, May 11 - 12th, 200612. Emory University, Atlanta, GA, Oct 2 – 3, 2008

Lectureships and Visiting Professorships (cont.)

13. Memorial Medical Center Grand Rounds, “Advancing Surgery: The Role of Quality Improvement and Clinical Trials”; Savannah, GA; October, 2009.

14. University of Chicago, “Creating Quality in Thoracic Surgery”, April, 2011.15. Mid-America Heart Institute, Kansas City, MO, April, 2011.

Other Presentations (state, local) Conferences

1. University of Texas Health Science Center, Limits of Surgical Resectability of Carcinoma of the Lung, Houston, TX, 10/89.

2. Critical Care Conference, Surgical Resection for Primary Carcinoma of the Lung, University of Texas MD Anderson Cancer Center, Houston, TX, 4/90.

38

Joe B. Putnam, Jr., M.D. Rev. December 20123. General Surgery Grand Rounds, University of Texas Medical School at Houston and Hermann Hospital -

Diagnostic and Management of Gastroesophageal Reflux, 6/91.4. Surgical Grand Rounds, University of Texas Health Science Center at Houston - Management of Pulmonary

Metastases, 9/915. Pathophysiology Conference, The University of Texas Health Science Center at Houston, Lung Carcinoma, 5/926. ATLS Provider Course, The University of Texas Medical School, Airway Management, 6/927. University of Texas M.D. Anderson Cancer Center, Surgery Symposium, Minimally Invasive Surgery in

Oncology, Thoracoscopic Resection of Mediastinal Tumors, Houston, TX, 12/92.8. Supportive Care Forum, University of Texas M.D. Anderson Cancer Center, Management of Pleural Effusion and

Ascites in Cancer Patients, 12/929. Minimal Access Surgery in Cancer Management Symposium, University of Texas M.D. Anderson Cancer Center,

Video Assisted Thoracoscopy, 12/92.10. Freshmen Medical Student Conference, University of Texas M.D. Anderson Cancer Center, Thoracic Surgical

Oncology, 7/93.11. Houston Cancer Institute 9th Annual Cancer Conference, Role of Surgery and its Operative Stages in the

Treatment of Non - Oat Cell Lung Cancer, Spring Branch Memorial Hospital, Houston, TX, 10/93.12. American Society of Abdominal Surgeons, 35th Clinical Congress of Abdominal Surgeons, Barrett’s Esophagus,

Houston, TX, 4/94.

Other Presentations (state, local) Conferences (cont.)

13. American Society of Abdominal Surgeons, 35th Clinical Congress of Abdominal Surgeons, Surgical Management of Esophageal Carcinoma, Houston, TX, 4/94.

14. Thoracic Surgery Journal Club Meeting, Veterans Hospital, Houston, TX, Esophageal Carcinoma, 5/94.15. ATLS Provider Course, Southeast Trauma Educational Foundation, Houston, TX, June 14 - 25, 1994.16. Advanced Cardiac Life Support (ACLS) Provider Course, Acid - Base Balance. University of Texas M.D.

Anderson Cancer Center, Houston, Texas, 7/94.17. Advanced Cardiac Life Support (ACLS) Provider Course, Airway Adjuncts and Intubation, University of Texas

M.D. Anderson Cancer Center, Houston, TX, 7/94.18. Houston Northwest Medical Center, Neo - adjuvant Chemotherapy plus Surgery in the Treatment of Potentially

Resectable Non - small Cell Lung Cancer, Houston, TX, 9/94.19. Texas Thoracic Society, Texas Pulmonary Medicine: A Comprehensive Review and Update, South Shore Harbor

Resort and Conference Center, League City, TX, 3/95.20. Thoracic Basis Science Lecture Series, Lung Cancer III, Baylor College of Medicine, Houston, TX, 7/95.21. Thoracic Basis Science Lecture Series,” Esophageal Cancer II, Baylor College of Medicine, Houston, TX, 9/95.22. Surgery Grand Rounds, Current Management of Esophageal Cancer, University of Texas Medical School and

Hermann Hospital, Houston, TX, 11/95. 23. Surgery Grand Rounds, Evolving Surgical Management of Pulmonary Metastases, University of Texas Medical

School and Hermann Hospital, Houston, TX, 11/96.24. Thoracic Basic Science Lecture Series, Pulmonary Metastases, Baylor College of Medicine, Houston, TX, 2/97.25. Thoracic Basic Science Lecture Series, Malignant Pleural Effusions, Baylor College of Medicine, Houston, TX,

3/97.26. 3rd Advanced Closed Circuit Endoscopy, Approach to Gastroesophageal Tumors, Houston, TX, 11/97.27. 3rd Advanced Closed Circuit Endoscopy (ACE), Surgeon’s Point of View, University of Texas M.D. Anderson

Cancer Center, Houston, TX, 11/97.28. Journal Club Conference, The Use of the Denver Catheter to Manage Pleural Effusion, The Department of

Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, 1/98.

29. Lung Cancer Therapy Retreat, Pulmonary Perfusion, University of Texas M.D. Anderson Cancer Center, Houston, TX, 2/98.

30. 41st Annual Clinical Conference, New Frontiers in Research and Treatment of Aerodigestive Tract Cancers, What is the Right Operation for Cancer of the Esophagus?, University of Texas M.D. Anderson Cancer Center, Houston, TX, 4/98.

31. Grand Rounds, UT Medical Health Science Center, Indications and Results of Lung Resection for Metastases, Houston, TX, 9/98.

32. The Third Houston Pulmonary and Critical Care Update, Multimodality Modality Treatment of Advanced Stage Carcinoma of the Lung, Houston, TX, 9/98.

39

Joe B. Putnam, Jr., M.D. Rev. December 201233. Thoracic Basic Science Lecture Series, Malignant Pleural Effusions, Baylor College of Medicine, Houston, TX,

9/98. 34. Grand Rounds, Evolving Role of the Surgeon in the Management of Advanced Stage Lung Cancer, Baylor

College of Medicine, Houston, TX, 9/99.35. Cancer Care, University of Texas M.D. Anderson Approach, Surgical Approach to Lung Cancer, University of Texas

M.D. Anderson Cancer Center, Houston, TX, 10/9936. Houston Surgical Society Lecture, Carcinoma of the Esophagus, Houston, TX, 10/00.37. Cancer Advisory Committee, Tumor Board: Emphasis on Thoracic Tumors, Houston, TX, 4/01.38. Grand Rounds Session Pearls - The Art and Science of Medicine, “Outpatient Management of Malignant Pleural

Effusions”, University of Texas M. D. Anderson Cancer Center, 6/01.39. AstraZeneca Preceptorship Program, Surgical Approaches to NSCLC, M. D. Anderson Cancer Center, Houston, TX,

2/0240. Spring Branch Medical Center 19th Annual Cancer Conference, Update on the Management of Lung Cancer, Houston,

TX, 10/02.41. University of Texas Health Science Center at Houston, Student Surgical Association Lecture Series, Houston, TX,

11/02.42. Nashville Surgical Society, Clinical Data Collection at the Point of Decision: A Model for Quality Improvement,

Nashville, TN, 09/04.43. Vanderbilt - Ingram Cancer Center, 2006 Spring Scientific Conference, Resection of Thoracic Neoplasms:

Implications for Multimodality Therapy, 04/06.

Other Presentations (state, local) Conferences (cont.)

44. 2nd Annual Advanced Lung Disease and Critical Care Conference, “New Treatment for Lung Cancer – the Cutting Edge”, Vanderbilt University Medical Center, Nashville, TN, December, 2006.

45. Grand Rounds Presentation, Aultman Cancer Center, Dayton, OH, April 200646. Vanderbilt Ingram Cancer Center Fall Oncology Conference, “The Role of Adjuvant Therapy Following

Resection of Non - Small Cell Lung Cancer: A Surgeon’s Perspective.” Braselton, GA, October, 2006.47. Riverside Hospital Grand Rounds, “Lung Cancer: Proposed Revisions in Lung Cancer Staging and Implications for

Multi - Modality Therapy”; Columbus, OH, November 2007.48. 32nd Matthew Walker Surgical Symposium, “Multidisciplinary Management Strategies for Esophageal

Carcinoma”; Meharry Medical College, Nashville, TN, May, 2008.49. Vanderbilt University Medical Center Department of Thoracic Surgery: Advances in the Treatment of Thoracic

Diseases: Lung Cancer Management Strategies and Practice. Speaker, “Update on Staging for Lung Cancer” , Moderator, Panel Discussion and Case Presentation, Nashville, TN, May 16, 2009.

50. Medical Center of Bowling Green (KY) CME Program, “American Joint Committee on Cancer (AJCC) Staging of Lung Cancer”, August, 2009.

51. Southern Thoracic Surgical Association Annual Meeting, “Accuracy of Surgeon and Trainee Estimates of Lung Resection Risk”, “Role of a Serum Proteomic Signature in the Management of Pulmonary Nodules” Marco Island, FL; November, 2009.

52. CME Symposium, St. Mary’s Hospital, Knoxville, TN: “American Joint Committee on Cancer (AJCC) Staging of Lung Cancer”; November, 2009.

53. Vanderbilt University Medical Center Department of Thoracic Surgery: Advances in the Management of Thoracic Diseases 2010: Multidisciplinary Evaluation and Therapy, Program Director, Nashville, TN, April 24, 2010.


55. Indiana University School of Medicine/The Academy for Continued Healthcare Learning. “Management of Early Stage NSCLC”, Town Hall on the Multidisciplinary Management of NSCLC: A Community Perspective, Nashville, TN, March 7, 2012.


57. North Texas Multi-Disciplinary Lung Cancer Symposium, “Stage II Lung Cancer : Surgery vs. Chemotherapy and Radiation Therapy”, Dallas, TX, October 12, 2012.

40

· web viewvaporciyan, a.a., walsh, g.l., sinner, m., and roth, j.a. the university of texas m. d....

Documents